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ABSTRACT
A multitude of organs play a critical role in managing metabolism including
the liver, pancreas, gut, brain, muscle, and adipose tissue. Abnormal function in
any one of these can offset the metabolic balance and negatively affect whole body
function thereby contributing to the development of metabolic complications and
obesity. Although no single metabolic abnormality is responsible for obesity,
understanding how normal cellular processes are regulated provides us with
knowledge to reverse them during times of dysfunction. The main focus of this
dissertation is on the regulation of adipose tissue due to its dual role of storing
excess lipids and endocrine organ capabilities. Adipocytes, along with a majority
of other cell types, are highly dependent on calcium (Ca2+), thus the role of Ca2+
and the involvement of the Ca2+ channel Transient Receptor Potential Canonical
1 (TRPC1) were studied. The evidence provided in this dissertation shows that
Ca2+ entry in adipocytes, especially upon store-depletion, plays an important role
in adipocyte differentiation, autophagy, and adipokine secretion and subsequently
metabolic regulation. The endogenous Ca2+ entry channel in both subcutaneous
and visceral adipocytes was found to be dependent on TRPC1-STIM1 complexes
and altering or blocking TRPC1 resulted in dysfunctional adipocytes.
Adipocyte differentiation, the process of pre-adipocytes converting to
adipocytes, is a tightly regulated process with Ca2+ dependency. Blockage of
xv

TRPC1-mediated Ca2+ entry with SKF-96365 inhibited differentiation which was
indicated by decreased lipid accumulation and expression of PPARg, FAPB4, and
perilipin in both subcutaneous adipose tissue (Subc AT) and visceral adipose tissue
(VAT). Loss of TRPC1 in either adipose tissue type resulted in a reduced ability to
differentiate which occurred prior to PPARg expression indicating TRPC1-mediated
Ca2+ entry is necessary for the initial stages of differentiation.
Diets high in fat induce unhealthy expansion of adipose tissue, while exercise
reduces adipocyte size and lipid content. Mice deficient of TRPC1 function and
challenged with both a high-fat diet and exercise had lower fat mass and fasting
glucose concentrations along with decreased adipocyte numbers. Further investigation
indicated a decrease in autophagy with a concurrent increase in apoptosis. Together,
this data shows that TRPC1 inhibits the positive effects of exercise under a high-fat
diet-induced obesity environment.
Adipose tissue is an important endocrine organ responsible for secreting a
number of cytokines, including adiponectin and leptin, which have a functional role in
modulating metabolism. Secretion of adiponectin from adipose tissue has been found
to be Ca2+ dependent, but the identity of the responsible Ca2+ channel is unknown.
This study provides evidence that TRPC1 deficient mice have reduced serum
adiponectin concentration which is believed to be due to an inability of adipose tissue
to properly secrete adiponectin. Further, it was shown that loss of TRPC1-mediated
Ca2+ influx is involved in SNARE complex formation necessary for proper exocytosis
of adiponectin loaded vesicles.
xvi

Serum adiponectin concentrations have been shown to be correlated to
adiponectin receptor expression, thus it was investigated whether reduces in serum
adiponectin concentrations observed in TRPC1 deficient mice was due to
dysfunctional adiponectin signaling in muscle. Within this study, it was observed that
skeletal muscle of TRPC1 deficient mice have reduced adiponectin targets including
PGC1α, lipid metabolism, and mitochondrial biogenesis mRNA expression. Though
data suggests AdipoRon initiated adiponectin signaling in muscle is Ca2+ and SOCE
dependent, TRPC1 is not a contributing member as loss of TRPC1 did not inhibit Ca2+
influx or PGC1α expression indicating decreased adiponectin targets is likely due to
reduce serum adiponectin concentrations.
Overall, evidence from the combined studies suggests TRPC1-mediated Ca2+
influx is an important regulator of adipocyte processes necessary for maintaining a
healthy body.
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CHAPTER I
INTRODUCTION

Calcium Signaling
The ability of cells to communicate with their environment and respond
temporarily to external events is a critical cellular function. This process, called cell
signaling or signal transduction, is initiated by a receptor-ligand interaction which
triggers a chain reaction of biochemical and molecular steps which alter cell
physiology. Calcium (Ca2+) signaling is a particular subtype of cell signaling that
involves altering the cellular balance of internal versus external cellular Ca2+
concentrations. The Ca2+ ion is an important secondary messenger molecule
involved in regulating numerous cell processes including cell proliferation and
differentiation, motility, gene transcription, and exocytosis (Berridge et al., 2000).
At basal conditions, the free intracellular calcium concentration ([Ca2+]i) is
measured at ~100 nM, while the extracellular concentrations are more than
20,000-fold greater (Clapham, 2007). Cell stimulation can be in the form of
electrical, hormonal, or mechanical and can increase the [Ca2+]i to around 1,000
nM. Increases in [Ca2+]i are the result of either direct Ca2+ entry from the
extracellular milieu upon membrane depolarization (Woodard and Rosado, 2005)
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Figure 1 Cellular Ca2+ Regulators
Schematic diagram of common Ca2+ signaling pathways. Many cells contain
multiple pathways, but not necessarily all mechanisms shown here are present
in one single cell type. Influx of Ca2+ is primarily mediated by voltage-operated
channels (VOCs or VGCCs), receptor-mediated Ca2+ entry (ROC), transient
receptor potential channels (TRP), ligand-gated channels, and store-operated
Orai channels (SOC) that are activated by STIM1 protein. Efflux of Ca2+ is
achieved by PM Ca2+ ATPase (PMCA) or Na+/ Ca2+ exchanger (NCX). Release
of Ca2+ from the ER is mediated through IP3 (IP3R) receptors. The reuptake of
Ca2+ into the ER is mediated by ER Ca2+ATPase (SERCA). Other components
shown

include:

GPCR

(G

proteins);

PIP2

(phosphatidylinositol

4,5-

bisphosphate); PLC (phospholipase C); PKC (protein kinase C); DAG
(diacylglycerol); IP3 (inositol 1,4,5-trisphosphate); (IP3R inositol 1,4,5trisphosphate receptor). Reprinted from “Functional role of TRP channels in
modulating ER stress and Autophagy” by P. Sukumaran, 2016, Cell Calcium,
60, 123-132. Copyright 2016 by Elsevier. Reprinted with permission.
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or by the process of store-operated Ca2+entry (SOCE), which includes the release
of Ca2+ stores from the endoplasmic reticulum (ER) that initiates an influx of Ca2+
from the extracellular milieu (Parekh and Putney, 2005; Putney, 1986; Putney et
al., 2017).
The direct method of Ca2+ entry involves the opening of selective
Ca2+ channels in the plasma membrane (PM) thus triggering a rapid inflow of
Ca2+ ions. The most widely understood Ca2+ channels in this process are voltageoperated channels (VOCs or VGCCs), which are found in excitable cells and are
activated by changes in electrical membrane potential near the channel (Figure 1).
VOCs are generally ion-specific and channels have been identified for sodium
(Na+), potassium (K+), Ca2+, and Chloride (Cl-). The ability of VOCs to promptly
influx Ca2+ is needed for cellular processes such as muscle contraction or
exocytosis at synaptic endings (Berridge et al., 2003). Along with VOCs, there are
many other Ca2+ channels that are initiated by different external signals including
receptor-operated channels (ROCs), such as the NMDA (N-methyl-D-aspartate)
receptors (NMDARs) that respond to glutamate. At the end of the signaling event,
Ca2+ is removed out of the cytoplasm to return the cell to basal [Ca2+]i through PMassociated pumps and exchangers. The plasma membrane Ca2+ ATPase (PMCA)
is important for this process and has low capacity but high affinity for Ca2+ transport
with a stoichiometry of one Ca2+ ion to one ATP (Lopreiato et al., 2014). The
Na+/Ca2+ (NCX) also performs this job, however, has a low Ca2+ affinity but high
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capacity for Ca2+ transport giving it the ability to transport Ca2+ quickly out of the
cell but only at higher concentrations (Brini and Carafoli, 2011).
Within the cell, Ca2+ is stored inside the ER, mitochondria, lysosomes, Golgi
and nucleus (La Rovere et al., 2016). The ER is the main Ca2+ storage organelle
boasting relatively high Ca2+ concentrations that can be quickly released into the
cytoplasm. SOCE was identified in 1986 and is a ubiquitous PM Ca2+ entry
mechanism. The process begins with a ligand, such as a hormone,
neurotransmitter, growth factor, glycoprotein, or cytokine, binds to a G proteincoupled receptor (GPCR), thereby activating the receptor (Putney, 1986) (Figure
1). Ligand docking dissociates GDP from the G protein complex, resulting in the
detachment of G-alpha subunit and G-beta/G-gamma complex. The GTP bound
G-alpha subunit then docks to Phospholipase C (PLC) causing a conformational
change of PLC and hydrolyzing phosphatidylinositol biphosphate (PIP2) into the
secondary messengers diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3)
(Berridge, 1993). The role of the freed IP3 is to bind with IP3 receptors bound to
the PM of the ER thus initiating an efflux of ER Ca2+ stores necessary for the
signaling event (Berridge et al., 2003). When the Ca2+ level in the ER lumen drops
following IP3 receptor binding, stromal interaction molecule (STIM), a family of
single-pass ER membrane bound proteins, senses the depleted Ca2+ and
translocates to the cell’s PM where it activates selective plasma membrane
Ca2+ channels called SOCs (store-operated Ca2+ channels) to transport
Ca2+ across the PM from the extracellular milieu (Prakriya and Lewis, 2015). Due
4

to the limited quantity of Ca2+ stored of the ER, ER Ca2+ release can only produce
transient signals; however, sustained store depletion can induce Ca2+ entry
through SOCs that is prolonged for minutes to hours. SOCs are not voltage
dependent, thus they can conduct Ca2+ at negative membrane potentials and are
complementary to VOCs. The first SOCs were identified in mast cells after whole
cell patch clamp recordings identified a Ca2+-selective current which was
characterized by an inward rectification and a reversal potential > +40 mv (Hoth
and Penner, 1992; Parekh et al., 1997). These channels were termed Ca2+
release-activated Ca2+ (CRAC) channels and include ORAI1, ORAI2, and ORAI3.
The transient receptor potential canonical family (TRPC) of Ca2+ channels has also
been identified as SOCs and will be discussed more readily in the following
sections. The induction of Ca2+ influx by SOCs results in an increase in [Ca2+]i
which is used for the signaling event and to refill the ER via the Ca2+-ATPase
pump, sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) and the golgi via the
secretory pathway Ca2+ ATPase (SPCA) (Guerini et al., 2005; Strehler and
Treiman, 2004). Termination of SOCE occurs following the refilling of the ER by
SERCA and SOCs return to their original positions (Cao et al., 2015; Jousset et
al., 2007; Manjarrés et al., 2011).To respond dynamically to the fluctuations of Ca2+
signaling needs, cells must be able to accurately control the amount and location
of Ca2+ influxed through Ca2+ transporters and channels. In the next section, we
will discuss a particular group of Ca2+ channels important for this process.
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TRP Family of Ion Channels
The transient receptor potential channel genes were first discovered in the
fruit fly Drosophila melanogaster during research centered on understanding the
Drosophila melanogaster phototransduction cascade in the retina (Cosens and
Manning, 1969). It was found that light-induced conformational changes of the
protein rhodopsin stimulated the attached GTP-binding protein thereby activating
phospholipase-C and an influx of cations. Within this study, a spontaneously
formed mutant with a blind phenotype was analyzed and the correlating gene
mutation caused a transient cation influx response to light instead of the expected
sustained response. Due to these results, the mutated gene and the corresponding
protein were given the name trp for Transient Receptor Potential (Cosens and
Manning, 1969). Further research identified that the decline of photoreceptor
potential in the trp mutant was due to exhaustion of Ca2+ mobility of TRP and
resulted in a tenfold decrease in Ca2+ influx (Vaca et al., 1994; Xu et al., 1997).
Since the structure of the mutated trp protein resulting in changes in Ca2+
permeability was similar to other known cation channels, it was hypothesized to be
a new Ca2+ channel involved in the inositol phosphate signaling system (Hardie
and Minke, 1992; Montell, 1999; Montell and Rubin, 1989). Subsequent
investigation revealed numerous TRP channels which were grouped into a family.
TRP channels are tetrameric complexes consisting of four pore-forming
units (Figure 2). Each unit contains six hydrophobic stretches and a pore loop motif
intercalated between the fifth and sixth transmembrane segments (Dietrich et al.,
6

2014; Nilius, 2007; Pani et al., 2008; Venkatachalam and Montell, 2007). The 1275
amino acid protein has 3 domains with a neutral 333 amino acid N-terminal
domain, followed by a 228-amino acid domain with 6 transmembrane segments
and a hydrophilic 614 amino acid C-terminal domain. The Transient Receptor
Potential superfamily is broken into seven subfamilies which are separated into
two groups based on sequence and topological differences. Group 1 consists of
five subfamilies and includes TRPC (Canonical) (TRPC1–TRPC7), TRPCV
(Vanilloid) (TRPV1–TRPV6), TRPM (Melastatin) (TRPM1–TRPM8), and TRPA
(Ankyrin) and TRPN (NOMPC-like). Group 2 includes TRPP (polycystin) (TRPP1TRPP2) and TRPML (mucolipin) (TRPML1-TRPML3). Of all the mammalian TRP
channels, the members of the TRPC sub family are the most closely related to the
Drosophila TRP (Birnbaumer, 2009; Montell, 2005; Putney, 1986, 1990).

7

Figure 2 TRP Channels
Phylogenetic tree and topology of TRP channels grouped by structural
similarities. Subfamilies include TRPC (Canonical) (TRPC1– TRPC7), TRPCV
(Vanilloid) (TRPV1–TRPV6), TRPM (Melastatin) (TRPM1–TRPM8), and TRPA
(Ankyrin) and TRPN (NOMPC-like), TRPP (polycystin) (TRPP1-TRPP2) and
TRPML. Reprinted from “TRP Channels in Disease” by B. Nilius, 2005, Science
Signaling, 2005, 295. Copyright 2005 by The American Association for the
Advancement of Science. Reprinted with permission.
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TRPC Subfamily
Expression of TRPC channels is ubiquitous in nature and have been found
in a wide variety of tissues including the brain, hypothalamus, adipose tissue,
smooth and cardiac muscles, endothelium, kidney, adrenal gland, lung, and
pituitary glands (Pedersen et al., 2005; Qiu et al., 2010; Sukumar et al., 2012;
Zanou et al., 2010). The first mammalian TRPC channel to be identified and cloned
was TRPC1 which lead to the identification of the other members (Wes et al.,
1995). The human TRPC subfamily contains seven members which are separated
into two individual groups (Figure 3) based on their biochemical and functional
similarities: TRPC1/4/5 and TRPC3/6/7 (Ong and Ambudkar, 2017). TRPC
channels are non-selectively permeable to Ca2+, but the selectivity ratio of
PCa/PNa varies significantly between groups (Ong and Ambudkar, 2017;
Venkatachalam and Montell, 2007). Sequence homology in TRPC channels is
found within the block of roughly 25 residues on the C-terminal tail termed the TRP
domains which includes TRP boxes 1 and 2. TRP box 1 is a conserved amino acid
sequence of EWKFAR and TRP box 2 is a six-amino acid proline-rich domain. The
C-terminal tail also includes binding domains for PIP2 and calmodulin (CaM)
named CIRB. The N-terminal tail of TRPCs contains 3-4 ankyrin repeats and a
coiled-coil domain of alpha-helices (Ong and Ambudkar, 2011). The domains for
Homer1, IP3R and caveolin-1 (Cav-1) binding have also been uncovered, but the
exact function of each of these remains elusive.

9

All TRPC channels are activated by PIP2 hydrolysis and ER Ca2+, though
not all are involved in SOCE mechanisms (Ong and Ambudkar, 2015). Importantly,
none of the TRPCs exhibit currents similar to CRAC channels. TRPC channels
display currents with a relatively linear current-voltage relationship with a reversal
potential from zero to slightly positive, however this can vary based on cell type
and complex formation (Cheng et al., 2013). Figure 3 shows representative
current-voltage relationships for groups of TRPCs. The TRPC channels 3/6/7 are
unique to the TRPC family as they may be directly activated by DAG or its
metabolite polyunsaturated fatty acid (PUFAs) (Poburko et al., 2007;
Venkatachalam

and

Montell,

2007).

One

study

showed

exposure

of

overexpressed TRPC3 channels to exogenous DAG/PUFAs resulted in Ca2+
transients indicating TRPC3 channel activation, however, in the presence of DAG
activated protein kinase C (PKC), TRPC3 channels were inhibited (Soboloff et al.,
2007). In this instance, it was surmised that PKC activation by DAG may be a
feedback control for TRPC channels.
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Figure 3 TRPC Channels
(A) Common topography of TRPC channels along with specific currentvoltage relationships shown below for each TRPC channel grouping. (B)
Phenotype of TRPC channel genetic deletions. The TRPC7 -/- phenotype has
not been reported and TRPC2 is a pseudogene in humans. Reprinted from
“International Union of Basic and Clinical Pharmacology. LXXVI. Current
progress in the mammalian TRP ion channel family” by L-J. Wu, 2010,
Pharmacological Reviews, 2010;62(3):381:404. Copyright 2010 by American
Society for Pharmacology and Experimental Therapeutics. Reprinted with
permission.
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TRPC1 Involvement in SOCE
Data suggests that TRPCs contribute to SOCE mechanisms, although
certain TRPCs have varying findings. The most consistent and soundest studies
support a role for TRPC1 in SOCE, however activation of TRPC5, TRPC6, and
TRPC7 seem to be also activated via store-independent mechanisms (Cheng et
al., 2013). TRPC3 and TRPC4 have also been implicated in SOCE, although to a
lesser degree.
The first evidence of involvement of endogenous TRPC1 in SOCE and
confirmation of its contribution to Ca2+ permeability was found in human
submandibular gland (HSG) ductal cells showing that knockdown of TRPC1
decreased SOCE functionality (Liu et al., 2003). The relative Ca2+-selective
currents were not consistent to those of CRAC channels, hence, the TRPC1mediated currents were termed store-operated calcium current channels (ISOC) as
they have a reversal potential that is outward rectifying at roughly +15 mV. It had
been previously established that STIM1 and ORAI1 were necessary components
of SOCE in that knockdown of either protein abolished SOCE currents (Cheng et
al., 2008; Jardin et al., 2008; Kim et al., 2009). It was further found that elimination
of either ORAI1 or STIM1 completely abolished TRPC1-mediated SOCE. The
current understanding of SOCE mechanisms, shown in Figure 1, is that after ER
Ca2+ store release, STIM1 interacts with both ORAI1 and TRPC1, however a
preceding ORAI1-mediated Ca2+ influx is required for TRPC1 function (Ambudkar
et al., 2017).
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Within this study, we utilize the
TRPC1-/- mouse which is missing a coding
region of exon 8 (Liu et al., 2007). This
deletion results in a loss of portions of
Figure 4 Confirmation of TRPC1
transmembrane segments 4 and 5 along

loss in subcutaneous adipose

with a small part of the putative pore

tissue

domain

be

RT-PCR expression of TRPC1 from

expressed but nonfunctional. Confirmation

subcutaneous adipose tissue of WT

causing

the

protein

to

of its competence has been well reported,

and TRPC1-/- mice

however we confirmed the absence of
TRPC1 in subcutaneous adipose tissue by assessing TRPC1 mRNA (Figure 4).

Metabolism Regulation
It is well understood that managing energy within the body to create a
relatively stable internal environment, or metabolic energy homeostasis, is
imperative for survival. Metabolic energy homeostasis is maintained by numerous
mechanisms

which

monitors

systemic

nutritional

status

and

responds

appropriately, both behaviorally and metabolically, to changes in energy
availability (Yamada et al., 2008). The amount of energy available is in limited
supply requiring tight regulation so that each organ/tissue and consequently its
cells function properly. Communication between organs in the form of neuronal
and hormone signals is imperative, and dysfunction can lead to an imbalance of
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metabolic homeostasis resulting in metabolic disorders. As shown in Figure 5,
adipose tissue is a major organ responsible for regulating metabolism. Dysfunction
in adipose tissue is thought to contribute toward a proinflammatory, atherogenic,
and diabetogenic state along with being linked to the development of chronic
inflammation, insulin resistance, metabolic syndrome and other obesity related
disorders (Klöting and Blüher, 2014). An understanding of how adipose tissue
modulates normal cellular processes is the first step in understanding disease
related dysfunction. In the following chapters, I will discuss how the involvement of
TRPC1 in adipose tissue is imperative to maintaining proper function needed for
metabolic energy homeostasis.
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Figure 5 Inter-tissue Communication
Humoral and neuronal pathways allow communication between major organs
to regulate metabolic information. Neuronal networks controlled by the brain
function as a negative-feedback mechanism to maintain body weight
homeostasis, while the liver and other organs possibly representing a
positive-feedback mechanism. Reprinted from “Inter-organ metabolic
communication involved in energy homeostasis: Potential therapeutic targets
for obesity and metabolic syndrome” by T. Yamada, 2008, Pharmacology and
Therapeutics, 117(1),11. Copyright 2008 by Elsevier. Reprinted with
permission.
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CHAPTER II
METHODS
Animals
Chapter III &V
Male B6129SF2/J (WT) or TRPC1 knockout (TRPC1-/-) mice (Jackson
Laboratories, Bar Harbor, MI) were used for these experiments. All animals
were housed in a temperature controlled room under a 12/12 h light/dark
cycle with ad libitum access to food and water. All animal experiments were
carried out as per the institutional guidelines for the use and care of animals.
For high-fat diet and exercise experimentation, four month old males were
fed diets containing either 16% (normal-fat, NF) or 45% fat (high-fat, HF) for
12 weeks and subjected to voluntary wheel running exercise. All animal
protocols were approved by the institutional IACUC committee.

Chapter IV
Four-month-old male B6129SF2/J (WT) or TRPC1 knockout (KO) mice
(Jackson Laboratories, Bar Harbor, MI) were fed diets containing either 16%
(normal-fat, NF) or 45% fat (high-fat, HF) for 12 weeks and subjected to
voluntary wheel running exercise (exercise, E) or sedentary cage activity
(sedentary, S). Experimental groups were labeled according to diet and
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exercise conditions yielding eight groups: WT-NF-E, WT-NF-S, WT-HF-E,
WT-HF-S, KO-NF-E, KO-NF-S, KO-HF-E, and KO-HF-S. Food intake, body
weight, and body composition were measured biweekly on alternating
weeks during the experimental feeding period. After 12 weeks, mice were
injected with xylazine (Akorn Inc., Decatur, IL) and ketamine (Zoetis Inc.,
Kalamazoo, MI) and then killed by exsanguination according to the animal
use and care protocol approved by the USDA Agricultural Research Service
Animal Care and Use Committee.

Stromal vascular fraction (SVF) and primary adipocyte isolation
Subcutaneous and visceral adipose tissue were weighed and digested with
0.5% collagenase type I (Gibco Thermo Fisher Scientific, Waltham, MA) at
37°C for 1 h, adipose tissue cells were filtered using 100 μm nylon cell
strainers (Corning Life Sciences, Tewksbury, MA) followed by centrifugation
(1000 rpm, 10 min, 4°C) to separate floating primary adipocytes
(supernatant) from adipose SVF (cell pellet). The SVF cell pellet was treated
with RBC lysis buffer (Sigma Aldrich, St. Louis, MO) then quenched with
DMEM (Dulbecco's modified Eagle's medium; high glucose, L-glutamine)
and centrifuged (1000 rpm, 10 min, 4°C). Final pellet was resuspended with
DMEM + 10% FBS. SVF was plated at 70-80% confluence and grown in
DMEM + 10% FBS + Penicillin Streptomycin.
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Adipose cell size and number determination
The supernatant from digested adipose tissue (see above) was washed and
resuspended in 0.9% NaCl. Adipose cell size and number determination
was determined using a Beckman Coulter Multisizer 4 with a 400-μm
aperture. The instrument was set to count 6000 particles and the cell
suspension was diluted so that coincident counting was <10%. After
collection of pulse sizes, the data were expressed as cell numbers per
particle diameter.

SVF differentiation
SVF was grown to a minimum of 80% confluence and differentiated for 36
hours in a cocktail of DMEM (10% FBS + Pen/Strep), 25mM glucose, 2 uM
dexamethasone (Sigma Aldrich, St. Louis, MO), 300 nM insulin (Sigma
Aldrich, St. Louis, MO), and 20 uM PGJ2 (Caymen Chemical, Ann Arbor,
MI). After 36 hours of differentiation, media was removed and cells were
grown in DMEM (10% FBS + Pen/Strep) for 7-10 days.

Chapter III
For differentiation experiments utilizing SKF and increased Ca2+
concentrations, cells were differentiated with the addition of SKF96365
(Sigma Aldrich, St. Louis, MO) or CaCl2. Final concentrations of Ca2+ were
1x-1.8 mM, 2x-3.6mM, 4x-5.4mM.
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C2C12 cell culture and differentiation
The mouse skeletal cell line C2C12 was cultured in DMEM (Dulbecco's
modified Eagle's medium; high glucose, L-glutamine) + 20% FBS + 1%
Pen/Strep and incubated at 37 °C, 5% CO2. At 80% confluence media was
switched to DMEM + 2% horse serum + 1uM Insulin for 3 days and then
DMEM + 2% horse serum for the remaining 4-7 days until fully
differentiated.

EchoMRI measurements of body composition
Whole body composition, including fat mass and lean mass, was
determined biweekly during the 12 week period without sedation using
nuclear magnetic resonance technology with the EchoMRI700™ instrument
(Echo Medical Systems, Houston, TX).

Red Oil Staining
Culture plates were washed by PBS and cells were fixed in 4% formalin,
followed by staining with oil-red-O (Sigma Aldrich, St. Louis, MO) for 10 min,
washed, and photographed. The dye was then extracted with 100%
isopropanol and the absorbance was determined at 492 nm.
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Gas chromatography/mass spectrometry (GC/MS)
Tissue samples were pulverized under liquid nitrogen conditions to a fine
homogeneous powder. Lipids were extracted with hexane/2-propanol
(3:2, v/v, HIP) as previously described (Saunders and Horrocks, 1984).
Briefly, ~10 mg of tissue powder was homogenized in 2 ml of HIP using a
2 mL Tenbroeck tissue grinder (Kontes Glass Co.). HIP contained
0.005% of butylated hydroxytoluene (BHT) to prevent fatty acid oxidation,
and a mixture of stable isotope labeled internal standards (Cambridge
Isotope Laboratories, Tewksbury, MA) for quantification. For each
sample, we used 100 ng of 10:0-2H17 for short chain FA quantification, 5
µg of 16:0-13C16 for saturated long chain FA, 1 µg of 18:1-13C18 for
monounsaturated FA, and 1 µg of 20:4n6-2H8 for polyunsaturated FA.
After centrifugation, HIP supernatant was evaporated under a stream of
nitrogen and subjected to saponification to release FA as previously
described (Brose et al., 2014). Briefly, lipids were re-dissolved in 260 µL
of methanol containing 0.02% BHT (0.158mg/mL) add 40 µL 5M KOH (in
water), and saponified at 60°C for 60 min in a water bath. The solution
was neutralized with the addition of 20 µL 5 M HCl followed by the addition
of 780 µL 0.9% NaCl. The free FA were extracted with 2 mL hexane 3
times. The hexane extracts were combined, dried under nitrogen stream,
re-dissolved in 1 mL of hexane, 100 µL (for short chain FA) or 1 µL (for
long chain FA) was transferred into micro-inserts (National Scientific,
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Rockwoods, TN; catalog No. C4010-S630), evaporated under nitrogen
stream, and finally re-dissolved in 100 µL of the initial UPLC gradient for
analysis.
UPLC-MS analysis was performed as previously described (Brose et al.,
2014; Wang et al., 2014). The UPLC system consisted of a Waters
ACQUITY UPLC pump with a well-plate autosampler (Waters, Milford,
MA) equipped with an ACUITY UPLC HSS T3 column (1.8 µM, 100 A pore
diameter, 2.1×150 mm, Waters) and an ACUITY UPLC HSS T3 Vanguard
precolumn (1.8 µM, 100 A pore diameter 2.1 × 5 mm, Waters). One
microliter of a sample was injected onto the column. The column
temperature was 55°C and the autosampler temperature was 8°C.
Solvent A consisted of acetonitrile : water (40 : 60) with 10 µM ammonium
acetate and 0.025% acetic acid. Solvent B was acetonitrile : 2-propanol
(10 : 90) containing 10 µM ammonium acetate and 0.02% acetic acid. The
flow rate was 0.3 mL/min, and the initial %B was 30%. At 0.1 min %B was
increased to 54% over 10 min, to 99% over another 10 min, held at 99%
for 8 min, and then returned to initial conditions over 0.5 min. The column
was equilibrated for 2.5 min between injections.
FA were quantified using a quadrupole time-of-flight mass spectrometer
(Q-TOF, Synapt G2-S, Waters) with electrospray ionization in negative ion
mode as described previously (Brose et al., 2014; Wang et al., 2014). The
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analyzer was operated with extended dynamic range at 10,000 resolution
(fwhm at m/z 554) with an acquisition time of 0.1s. MSE mode was used to
collect data. Leucine enkephalin (400 pg/µl, ACN : water, 50 : 50 by
volume) was infused at a rate of 10 µl/min for mass correction. MassLynx
V4.1 software (Waters) was used for instrument control, acquisition, and
sample analysis. FA were quantified against corresponding internal
standards using generated standard curves.
Blood collection and serum isolation
Mice were anaesthetized with an injected of xylazine (Akorn Inc., Decatur,
IL) and ketamine (Zoetis Inc., Kalamazoo, MI). A 3 cc syringe with a 22-25
gauge x 1" needle was inserted from the posterior aspect and animal was
terminally bled. Whole blood was allowed to coagulant for 30 min at room
temperature. Blood was then centrifuged at 2,000 x g for 15 minutes at 4°C
and serum was removed from clotted blood and frozen at -20°C.

Adiponectin and Leptin Concentrations
Serum, culture media, and protein lysates samples were analyzed for
adiponectin and leptin using the adiponectin mouse ELISA kit (Abcam,
Cambridge, UK) and Leptin Mouse ELISA kit (Invitrogen, Carlsbad, CA).
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Glucose tolerance test
At the end of 12 weeks of feeding, mice were fasted overnight and then
injected with 2 g/kg body weight of 20% D-glucose (Sigma Aldrich, St. Louis,
MO) intraperitoneally. Approximately 5 μl of tail blood, obtained through tail
nick procedure, was used to measure the blood glucose concentrations
using the Accu Check Aviva glucometer at baseline and then 15, 30, 60 and
120 min post glucose injection.

Measurement of plasma insulin
Mice were fasted overnight and then plasma was obtained to analyze insulin
concentrations (Insulin ELISA kit: EXRMI-13K, EMD Millipore, St. Charles,
MO) using the Bio-Rad Luminex system (Hercules, CA) according to
manufacturer’s protocols.

Electrophysiology
For patch clamp experiments, coverslips with cells were transferred to the
recording chamber and perfused with an external Ringer's solution of the
following composition (mM): NaCl, 145; CsCl, 5; MgCl2, 1; CaCl2, 1; Hepes,
10; Glucose, 10; pH 7.3 (NaOH). Whole cell currents were recorded using
an Axopatch 200B (Axon Instruments, Sunnyvale, CA, USA). The patch
pipette had resistances between 3 -5 MΩ after filling with the standard
intracellular solution that contained the following (mM): cesium methane
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sulfonate, 150; NaCl, 8; Hepes, 10; EGTA, 10; pH 7.2 (CsOH). Basal leak
was subtracted from the final currents and average currents are shown. The
maximum peak currents were calculated at a holding potential of –80 mV.
The voltage-current (I-V) curves were made using a ramp protocol ranging
from -100mV to +100mV and 100ms duration were delivered at 2s intervals,
whereby current density was evaluated at various membrane potentials and
plotted.

Calcium imaging
Cells were incubated with 2uM Fura-2 (Molecular Probes, Eugene, OR,
USA) and the fluorescence intensity was monitored with a CCD camerabased imaging system (Compix, Cranbery, PA, USA) mounted on an
Olympus (Shinjuku, Tokyo, Japan) XL70 inverted microscope equipped
with an Olympus 40× (1.3 NA) objective. A dual wavelength monochromator
enabled alternative excitation at 340 and 380 nm, whereas the emission
fluorescence was monitored at 510 nm with an Orca Imaging camera
(Hamamatsu, Shizuoka Prefecture, Japan). Fluorescence traces shown
represent [Ca2+]i values in 340/380 nm ratio that are a representation of
results obtained in at least 3-4 individual experiments using 40-70 cells in
each experiment.
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PCR analysis
Adipose tissue
Total RNA was extracted using the RNeasy Lipid Tissue Mini kit and
Qiacube (Qiagen, Valencia, CA) from flash-frozen subcutaneous adipose
tissue. cDNA was synthesized using the Quantitect Reverse Transcriptase
kit (Qiagen, Valencia, CA) Rox FastStart Universal Probe Master mix assay
reagents were purchased from Roche (Indianapolis, IN). Primers were
purchased from Integrated DNA Technology (IDT, Coralville, IA). The
endogenous control (18S rRNA) was purchased from Applied Biosystems
(Foster City, CA). RT-PCR analysis for TRPC1 transcripts was done with
primers

from

the

eighth

GCAACCTTTGCCCTCAAAGTG

and
and

ninth
Dn-5’

exons

(Up-5’

GGAGGAACATT-

CCCAGAAATTTCC) after the EcoRI site (Eurofins MWG Operon,
Huntsville, AL).

qPCR analysis
Chapter IV
Total RNA was extracted using the RNeasy Lipid Tissue Mini kit and
Qiacube (Qiagen, Valencia, CA) from flash-frozen hind leg biceps femoris
skeletal muscle or subcutaneous adipose tissue. cDNA was synthesized
using the Quantitect Reverse Transcriptase kit (Qiagen, Valencia, CA) and
then used to measure expression of glucose transporter type 4 (GLUT4),
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hypoxia-inducible factor 1-alpha (HIF1α), fibroblast growth factor 21
(FGF21), peroxisome proliferator-activated receptor gamma (PPARγ),
microtubule-associated proteins 1A/1B light chain 3A (MAP1LC3A), and
beclin 1 (BECN1) by qPCR (ABI Prism 7500 PCR System, Applied
Biosystems, Foster City, CA). Rox FastStart Universal Probe Master mix
assay eagents were purchased from Roche (Indianapolis, IN). Primers were
purchased from Integrated DNA Technology (IDT, Coralville, IA). The
control (18S rRNA) was purchased from Applied Biosystems (Foster City,
CA).

Chapter VI
Total RNA was extracted from liver and bicep femoris (BF) skeletal muscle
using Quick-RNA Miniprep kit (Zymo Research, Irvine, CA). cDNA was
synthesized using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA)
and expression was measured using SsoAdvanced Universal SYBR Green
Supermix (Bio-Rad, Hercules, CA). Primers were purchased from Thermo
Fisher (Waltham, MA) with the sequences in Table 1. Analysis of expression
was calculated by using the endogenous control (18S rRNA) and the ΔΔCT
method.
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Table 1 Primer Sequences
Symbol

Gene

Accession
number

ERRα

Estrogen-Related Receptor
Alpha

NM_007953.2

NRF1

Nuclear Respiratory Factor 1

NM_001293164.1

TFAM

Transcription Factor A

NM_001361693.1

ACC

Acetyl-Coenzyme A
Carboxylase

NM_133360.2

FASN

Fatty Acid Syntase

NM_007988.3

ACADM

Acyl-Coenzyme A
Dehydrogenase, Medium
Chain

NM_007382.5

PGC1a

PPARG Coactivator 1 Alpha

NM_008904.2

Primer Sequence
fwd-GGAAGTGCTGGTGCTGGGTGT
rev-GAATTGGCAAGGGCCAGAGCT
fwd-GGAGCACTTACTGGAGTCC
rev-CTGTCCGATATCCTGGTGGT
fwd-CCTGAGGAAAAGCAGGCATA
rev-ATGTCTCCGGATCGTTTCAC
fwd-GTCCCCAGGGATGAACCAATA
rev-GCCATGCTCAACCAAAGTAGC
fwd-AGAGATCCCGAGACGCTTCT
rev-GCCTGGTAGGCATTCTGTAGT
fwd-AGAGCTCTAGACGAAGCCACGA
rev-GAGTTCAACCTTCATCGCCATT
fwd-AAACTTGCTAGCGGTCCTCA
rev-TGGCTGGTGCCAGTAAGAG
fwd-GCCGCTAGAGGTGAAATTCTTG

18s

rev-CTTTCGCTCTGGTCCGTCTT

Muscle Isolation and Culture
Extensor Digitorum Longus (EDL) muscle was isolated from WT and
TRPC1-/- mice and digested using a solution of 0.2% Collagenase type I
(Gibco Thermo Fisher Scientific, Waltham, MA) in DMEM (Dulbecco's
modified Eagle's medium; high glucose, L-glutamine with 110 mg/ml sodium
pyruvate) for 1 hour at 37°C. Tissue was transferred to a horse serum lined
dish with DMEM and flushed until individual fibers were released from
tissue. Each fiber was moved to a separate dish coated with Matrigel
(Corning, Corning, NY) and suspended in DMEM with 20% FBS, 1%
Chicken Embryo extract (Accurate Chemical, Westbury, NY) and 1%
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Penicillin/Streptomycin. Myofibers were incubated for 4 days at 37 °C, 5%
CO2 without handling to allow myofibers to adhere and activate satellite
cells. Following that time frame, media was replaced every other day until
cells naturally differentiated ~ 14 days. Confirmation of differentiation was
obtained by visually observing new muscle formation and contraction.

Immunoblotting
Crude lysates were prepared from Subc AT and VAT and SVF and
differentiated adipocyte cultures. 40 μg of proteins were resolved on
NuPAGE Novex 4-12% Bis-Tris gels, transferred to nitrocellulose
membranes, and probed with respective antibodies (all from Cell Signaling).
Respective peroxidase conjugated secondary antibodies were used to label
the proteins, which were then detected by an enhanced chemiluminescence
detection kit (SuperSignal West Pico, Pierce, Appleton, WI). Densitometric
analysis was performed using image J analysis (National Institutes of
Health) and results were corrected for protein loading by normalization to
β-actin levels. Non-denaturing PAGE was performed by resolving protein in
Novex Tris-Glycine Native Sample Buffer on NuPAGE™ 3-8% Tris-Acetate
Protein Gels, transferred to nitrocellulose membranes, and probed with
respective antibodies. Membranes were stained with Ponceau S (Sigma
Aldrich, St. Louis, MO) and bands were quantified using image J analysis
to determine total protein load.
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Co-immunoblotting
Subc AT and VAT was manually homogenized in the presence of HBSS
containing Ca2+ and Mg2+ and then treated as described for 30 min at 37°C.
Samples were incubated overnight with anti-VAMP2 antibody after which
agarose anti-mouse IgG beads were added. Isolated beads were then
washed, boiled, and separated by SDS-PAGE. SNARE proteins were
detected using the indicated antibodies.

Adiponectin Secretion from Fresh Adipose Tissue
Isolated subcutaneous and visceral adipose tissue was suspended in
Hank’s balanced salt solution (HBSS) (Gibco) supplemented with 1.26 mM
CaCl2, 0.5 mM MgCl2, and 2% bovine serum albumin (Fisher Scientific,
Hampton, NH). Adipose tissue was cut into 8-15 mg pieces and suspended
in supplemented HBSS for 30 min at 37°C to recover. Samples were then
placed into a 96 well plate suspended in DMEM containing 2% BSA,
stimulated with 100 nM insulin (Sigma Aldrich, St. Louis, MO) for 6 hours.

Statistical Analysis
Mean and standard error values were computed for all continuous variables
and frequency distributions were calculated for all categorical variables
using GraphPad Prism 7. Statistical comparisons were made using twotailed Student’s t test or ANOVA and the effects of TRPC1 KO, diet, or
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exercise were assessed by three-way ANOVA. When an interaction was
significant (p < 0.05), Tukey contrasts were used to perform pairwise
comparisons. All statistical tests were two-tailed with significant reported as
follows: *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
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CHAPTER III
LOSS OF TRPC1 IN ADIPOCYTES IMPAIRS DIFFERENTIATION
Introduction
Intracellular Ca2+ signaling has been suggested to play several important
roles in regulating cellular energy metabolism (Filadi et al., 2017); however, the
specific Ca2+ ion channels involved have not yet been identified. As we’ve stated
before, TRPC1 functions as a Ca2+ entry channel that is found in key metabolic
tissues, including the hypothalamus (Qiu et al., 2010), adipose tissue (Sukumar et
al., 2012), and skeletal muscle (Zanou et al., 2010), making it a likely candidate for
the regulation of cellular energy metabolism. As such, functional disturbance of
TRP family channels could play a role in regulating adiposity and obesity-related
conditions such as insulin resistance (Graham et al., 2009; Hu et al., 2009;
Sabourin et al., 2015).
Adipocytes are vital to maintaining lipid homeostasis and energy balance
by storing triglycerides and releasing free fatty acids in response to energy need
changes (Rosen and Spiegelman, 2006). Though adipose tissue is an important
endocrine organ, excessive accumulation of adipose tissue, defined as obesity, is
a major risk factor for insulin resistance and other diseases such as Type II
diabetes, dyslipidemia, and cardiovascular disorders (Wu et al., 1999). Adipocytes
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are the predominant cell type in adipose tissue; however, not all adipose tissue
functions identically. Several studies have shown that anatomical distribution of
adipose tissue dictates differing characteristics where subcutaneous adipocytes
have distinct metabolic properties from visceral adipocytes (Baglioni et al., 2012).
Proliferation of the subcutaneous adipose tissue (Subc AT) may be considered
beneficial, in part, by increasing “healthy” lipid storage capacity that produces
fewer inflammatory cytokines. Whereas, visceral adipose tissue (VAT) is thought
to be more inflammatory (Kadiri et al., 2017; O'Rourke et al., 2009) and leads to
the development of obesity and related metabolic diseases (Foster et al., 2011;
Seale et al., 2011). Although the debate about the metabolic function of Subc AT
and VAT is not yet settled (Fabbrini et al., 2010; Thörne et al., 2002), variances in
distribution of lipids in Subc AT and VAT could be critical in the development of
metabolic diseases.
One such area to investigate regarding variances between Subc AT and
VAT tissues could be the process of differentiation of committed preadipocytes into
mature adipocytes. Interestingly, it has been shown that differentiation is impaired
in Subc preadipocytes of obese subjects and their ability to differentiate is
negatively correlated to BMI and cell size (Isakson et al., 2009). Further, in an
obese state, the preadipocyte to mature adipocyte ratio is reduced and the ability
of Subc AT to differentiate properly may be diminished pushing the accumulation
of fat to visceral depots (Tchoukalova et al., 2007). Similar results have shown an
age-dependent decline in differentiation and increases in adipose tissue
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Figure 6 Schematic of adipocyte differentiation
The induction of transcription factors C/EBPβ and C/EBPδ are induced early
during adipogenesis with PPARγ induction occurring shortly after. Lipid droplet
formation and expression of mature adipocyte proteins such as FAPB4, perilipin,
and adiponectin occur during the late stage. Reprinted from “Cellular models for
the evaluation of the antiobesity effect of selected phytochemicals from food and
herbs” by Y-C. Tung, 2017, Journal of Food and Drug Analysis, 25(1), 100-110.
Copyright 2017 by Elsevier. Reprinted with permission.

accumulation in obesity is likely due to hypertrophy instead of hyperplasia (Kim et
al., 2014).
Although several nuclear receptors and transcription factors that regulate
adipocyte differentiation and adipogenesis have been identified (Farmer, 2006),
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factors upstream to the activation of these transcription factors are still unknown.
Adipogenesis is an intricate process involving coordinated temporal and spatial
control of a transcriptional system which regulates the expression of adipocytespecific genes (Figure 6). The first step involves the initiation of the
CCAAT/enhancer-binding proteins (C/EBPs) family of transcription factors
including C/EBPβ and C/EBPδ with C/EBPα and Peroxisome proliferator–
activated receptor γ (PPARγ) activation occurring in the intermediate or late stage
of adipogenesis (Garin-Shkolnik et al., 2014). Although the C/EBP transcription
factors seem to work in conjunction with PPARγ, PPARγ has been determined to
have a dominant role and functions as a master regulator of adipogenesis (Haider
et al., 2017). PPARγ has been linked to the transcription of genes expressed in
mature adipocytes such as fatty acid binding protein (FABP4), required for
transport of free fatty acids, and perilipin (PLIN1), which covers the surface of
mature lipid droplets in adipocytes and regulates lipolysis. PPARγ also regulates
lipoprotein lipase (LPL), adiponectin (ADIPOQ), fatty acid transporter CD36
(CD36), glycerol-3-phosphate dehydrogenase (GPD1), and insulin-responsive
glucose transporter 4 (GLUT4), all involved in regulating lipid and glucose
metabolism (Rosen et al., 1999; Siersbaek et al., 2010; Tung et al., 2017). Not
surprisingly, several studies have demonstrated that PPARγ has a role in
metabolic diseases. Mutations to the PPARγ gene have been linked to type II
diabetes, obesity, hypertension and insulin resistance (Pap et al., 2016), while
adipose-specific knockout of PPARγ in mice fed a high-fat diet display insulin
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resistance in adipose tissue and liver, but not in muscle (He et al., 2003). PPARγ
agonists, such as rosiglitazone and pioglitazone, which are part of the
thiazolidinediones (TZD) family, have been widely used in the treatment of type II
diabetes due to their ability to enhance insulin sensitivity and increase adiponectin
levels (Mooradian et al., 2002; Saltiel and Olefsky, 1996; Yang et al., 2002).
Calcium has been identified as important for the transcriptional regulation
of adipocyte differentiation; however, the molecular identity of the Са2+ channel
has yet to be identified. Studies on preadipocytes show that elevating [Ca2+]i early
in differentiation inhibits PPARγ induction and triglyceride accumulation (Neal and
Clipstone, 2002; Shi et al., 2000). Similarly, elevating extracellular Ca2+
concentrations, with no change in [Ca2+]i, inhibited adipocyte differentiation in
white (Jensen et al., 2004) and brown (Pramme-Steinwachs et al., 2017)
adipocytes. In contrast, elevations of [Ca2+]i during late adipogenesis promoted
lipogenesis and GPDH activity in white adipocytes (Shi et al., 2000). Though
elevating extracellular calcium concentrations had negative effects on white and
brown adipocyte differentiation, reducing extracellular concentrations had the
opposite effect on brown adipocytes where decreased levels increased brown
adipocyte differentiation (Pramme-Steinwachs et al., 2017). Finally, initiating a
Са2+ response through the usage of angiotensin II is known to modulate adipocyte
proliferation and differentiation, triglyceride accumulation, expression of adipokineencoding genes and adipokine secretion (Shum et al., 2013). Together these
studies demonstrate the importance of modulating Са2+ during differentiation,
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however the mechanism and channel necessary is still unknown. Microarray
analysis has shown both TRPC1 and TRPC5 expression are amplified when 3T3L1 adipocytes mature; however, the physiological characterization of the Ca2+
entry channel in subcutaneous and visceral adipocytes is still missing (Sukumar et
al., 2012). Additional data from this study is shown in Figure 7 confirming the
expression of TRPC1 and TRPC5 in mouse epididymal adipose tissue and
perivascular adipose from humans with coronary artery disease (CAD). It is
notable that this study found TRPC1 expression surmounted TRPC5 expression
at both the RNA and protein level. It was also recently shown in El Hachmane et
al., 2018 that SOCE proteins STIM1, ORAI1, and TRPC1 are highly expressed in
3T3-L1 adipocyte cell line and play a functional role in SOCE mechanisms further
indicating the importance of TRPC1 in adipose function.
The aim of this study was to identify the endogenous Ca2+ entry channel in
adipocytes cells and establish its physiological function in modulating adipocyte
differentiation. We report for the first time the adipose tissue-dependent differences
in sensitivity to SOCE, differentiation, and lipid accumulation. We further report that
the endogenous Ca2+ entry channel in adipocytes is dependent on TRPC1 and
loss of TRPC1 function inhibits adipocyte differentiation. These results suggest
TRPC1 is crucial for adipocytes differentiation, which plays an important role in
regulating metabolic homeostasis.
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A

C

B

D

Figure 7 TRPC1 and TRPC5 expression in mouse and human adipose
(A) RNA RT-PCR products from mouse epididymal adipose tissue. Analysis of
mRNA from human coronary artery disease (CAD) perivascular adipose by RTPCR (B) and western blot protein (C). (D) Immunostaining (brown colour in the
upper panels indicates channel detection) of TRPC1 and TRPC5. The control
was the antibody (Ab) preadsorbed to its antigenic peptide (+pep). Scale bar,
100 μm. Reprinted from “Constitutively Active TRPC Channels of Adipocytes
Confer a Mechanism for Sensing Dietary Fatty Acids and Regulating
Adiponectin”, P. Sukumar, 2012, Circulation Research, 111(2), 191-200.
Copyright 2012 by Wolters Kluwer Health, Inc. Reprinted with permission.
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Results

Subcutaneous and visceral adipocytes display SOCE mechanisms
To establish the molecular identity of the SOCE channel in adipose cells,
we evaluated Ca2+ signaling in isolated stromal vascular fraction (SVF) of mouse
adipose tissue. Addition of thapsigargin (1mM, Tg), a SERCA pump blocker that
causes loss of Ca2+ from the internal ER stores, showed a small increase in
intracellular Ca2+ ([Ca2+]i ) levels (first peak) in subcutaneous adipose tissue (Subc
AT) SVF cells (Figure 8 A, B). Addition of 1mM external Ca2+, Subc AT SVF cells
showed a significant increase in [Ca2+]i (second peak), indicating the presence of
store-mediated Ca2+ entry (Figure 8 A, B). Importantly, Subc AT SVF cells treated
with SKF96365 (10mM SKF, a blocker of store-mediated Ca2+ influx channels)
were observed to have a significant reduction in SOCE without any change in
internal ER Ca2+ release (Figure 8 A, B).
To establish the molecular identity of the Ca2+ influx channel in Subc AT
SVF cells, electrophysiological recordings of membrane currents were performed.
Addition of Tg induced an inward current, which was non-selective in nature and
reversed between 0 and -5 mV (Figure 8 C, D). The current properties observed
in Subc AT SVF cells were similar with previous recordings observed of TRPC1
channels (Liu et al., 2004; Selvaraj et al., 2012; Shi et al., 2012; Yuan et al., 2007).
Moreover, pretreatment with SKF significantly inhibited the Tg-induced
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Figure 8 Subc AT SVF exhibits SOCE
Representative Fura-2 traces showing the transient increase in [Ca2+]i after
addition of 1 μM Tg and 1 mM Ca2+ to Subc AT SVF cells (A) in control and
cells pretreated with 10 μM SKF for 15 min. Bar diagram quantifies Tg-induced
ER Ca2+ release and Ca2+ entry peaks for Subc AT SVF cells (B) under these
conditions. Each bar gives the mean ± SEM of 40–60 cells in three separate
experiments. Application 1 μM Tg in bath solution induced inward currents at
−80mV in control and SKF treated Subc AT SVF cells (C). Respectively IV
curves under these conditions are shown for Subc AT SVF in (D). Quantitation
(n = 7 recordings) of current intensity at −80 mV is shown for Subc AT SVF in
(E). Graphs are mean ± SEM, significance: *, p < 0.05.
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nonselective current (Figure 8 C-E), suggesting that in Subc AT SVF cells, the
SOCE mechanism is dependent on TRPC1 channels.
We next evaluated the physiological properties of the SOCE channels in
differentiated adipocytes from Subc AT. Samples taken from both Subc AT
deposits were cultured and differentiated into mature adipocytes ex vivo. Similar
to the observed response in Subc AT SVF cells, differentiated Subc adipocytes
showed no change in the ER Ca2+ release (upon addition of Tg, 1mM) (Figure 9
A,B). Addition of 1mM external Ca2+ again resulted in an increase in [Ca2+]i, which
were significantly reduced when treated with SKF as compared to untreated
Control (Figure 9 A,B). Furthermore, a similar TRPC1-like current was observed in
differentiated Subc AT adipocytes during whole cell patch clamp recordings and
the Tg-induced currents were again inhibited by SKF (Figure 9 C-E). Comparison
of Current-Voltage (I-V) Curves of Subc AT SVF and differentiated Subc AT
adipocytes indicated a ~25% increase in amplitude of TRPC1-like currents in
differentiated Subc AT (Figure 8 E, Figure 9 E).
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Figure 9 Blockage of SOCE in differentiated Subc AT by SKF
Representative Fura-2 traces showing the transient [Ca2+]i after addition of 1 μM
Tg and 1 mM Ca2+ to differentiated Subc AT (A) in control and cells pretreated
with 10 μM SKF for 15 min. (B) Bar diagram quantifies Tg-induced ER Ca2+
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shown in (D). Quantitation (n = 7 recordings) of current intensity at −80 mV is
shown in (E). Graphs are mean ± SEM, significance: *, p < 0.05; ***, p < 0.001.
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To confirm that TRPC1 is involved in modulating SOCE, protein expression
of TRPC1, STIM1, and ORAI1 in both Subc AT SVF and differentiated Subc AT
was analyzed. Consistent with other studies, expression of TRPC1 and STIM1 was
increased upon differentiation (Graham et al., 2009; Sukumar et al., 2012);
however, there was no change in ORAI1 expression (Figure 10 A, C). Known
markers of adipocyte differentiation, FABP4 and perilipin, were used to confirm
differentiation.
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Figure 10 Changes in Ca2+ channel expression during differentiation in
Subc AT and VAT
Western blot and quantification of TRPC1, ORAI1, Stim1, FAPB4, and perilipin
protein expression normalized to actin of Subc AT SVF and differentiated Subc
AT (A,C) and VAT SVF and differentiated VAT (B,D). Graphs are mean ± SEM,
significance: *, p < 0.05; **, p < 0.01.
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Differentiated visceral adipocytes exhibit increased
store-operated Ca2+ entry
White AT has different properties based on its location. It is well known that
visceral adipose tissue (VAT), when compared with Subc AT, is functionally
different in that VAT has higher inflammatory potential (Zhou et al., 2007) due to
increased localization of inflammatory and immune cells. VAT has greater
oxidative capacity and lipolysis potential than Subc AT and less capacity to
differentiate resulting in a greater percentage of large adipocytes as compared to
Subc AT (Ibrahim, 2010). To date, it is unknown whether store-mediated changes
in [Ca2+]i leading to adipocyte differentiation is analogous between VAT and Subc
AT. Thus, we investigated SOCE from adipocytes derived from the VAT depots.
Consistent with Subc AT protein expression, STIM1, ORAI1 and TRPC1 were
expressed in both VAT SVF and differentiated VAT adipocytes with increased
expression of STIM1 and TRPC1 seen in differentiated VAT, and again no change
in ORAI1 expression (Figure 10 B, D).
Measurements of membrane current recordings of VAT SVF adipocytes
induced upon the addition of Tg (1mM) showed an inward TRPC1-like current and
pretreatment with SKF (10mM) significantly inhibited the nonselective current
(Figure 11 A, B). Importantly, after differentiation, the similar TRPC1-like current
was observed in VAT cells (Figure 11 D, E) and a ~50% increase in the current
amplitude was observed upon differentiation (Figure 11 C, F). Again Tg-induced
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currents were inhibited by the addition of SKF in differentiated VAT adipocytes
(Figure 11 D, E).
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Figure 11 Increased SOCE currents in differentiated VAT
Application of 1 μM Tg in bath solution induced inward currents at −80mV in
control and SKF treated VAT SVF cells (A) and differentiated VAT (D).
Respectively IV curves under these conditions are shown for VAT SVF in (B) and
differentiated VAT in (E). Quantitation (n = 5 recordings) of current intensity at
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mean ± SEM, significance: *, p < 0.05.
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Calcium imaging of VAT SVF adipocytes treated with SKF had no change
in internal Ca2+ release, but had a significant reduction in SOCE upon the addition
of 1mM external Ca2+ (Figure 12 A, B). However, differentiated VAT adipocytes
treated with SKF showed a reduction in both internal Ca2+ ER store release upon
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Figure 12 Fura-2 Traces of SVF and differentiated VAT
Representative Fura-2 traces showing the transient increase in [Ca2+]i after
addition of 1 μM Tg and 1 mM Ca2+ to VAT SVF cells (A) and differentiated
VAT (C) pretreated with 10 μM SKF for 15 min. Bar diagram quantifies Fura-2
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Tg treatment and SOCE upon addition of external Ca2+ which could be attributed
to slightly smaller ER stores in the cells sampled or a specific response of
differentiated VAT to SKF (Figure 12 C, D). These results indicate that
differentiated VAT adipocytes may be more sensitive to alterations in storeoperated Ca2+ entry than VAT SVF adipocytes, however the properties of both
Subc AT and VAT exhibit similar SOCE functionality.
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Figure 13 Inhibition of SOCE impairs ability of adipocytes to differentiate
(A) Oil-red-o staining (using 10X objective) of Subc AT and VAT differentiated in
the presence of SKF (10 µM) for 7 days. Quantification of absorbance at 492nm
of stained lipid droplets using eluted oil-red-o stain for Subc AT (B) and VAT (D).
Western blot of PPARg, FAPB4, and perilipin protein expression of Subc AT (C)
and VAT (E) differentiated in the presence of SKF. Graphs are mean ± SEM,
significance: ***, p < 0.001; ****, p <0.0001.
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Inhibition of SOCE impairs ability of adipocytes to differentiate
Impaired differentiation of preadipocytes has been shown in obese subjects
(Isakson et al., 2009). Interestingly, altering [Ca2+]i inhibits differentiation of
adipocytes (Jensen et al., 2004; Neal and Clipstone, 2002), however to date, it is
unknown whether store-mediated changes in [Ca2+]i leading to adipocyte
differentiation is analogous between VAT and Subc AT. To investigate, we first
blocked SOCE by pretreating cells with SKF and then initiated differentiation. Subc
AT and VAT SVF adipocytes were differentiated in the continuous presence of
SKF (10 mM) for 7 days and lipid accumulation was detected by oil-red-O (Figure
13 A). Oil-red-o stains neutral triglycerides and lipids and the absorbance at 492
nm can be used to quantify total lipid in sample. As such, treatment with SKF
significantly reduced the ability of both Subc AT and VAT SVF cells to accumulate
intracellular lipids (Figure 13 B, D). Expression of PPARg, FABP4, and perilipin is
absent in undifferentiated preadipocytes, thus measuring their protein expression
level is a measurement of adipogenesis. In both Subc AT and VAT, treatment with
SKF blocked nearly all expression of FABP4, perilipin, and PPARg (Figure 13 C,
E). These results further indicate the involvement of SOCE mediated Ca2+ influx in
adipocyte differentiation and that it may be necessary for early stages of
transcriptional regulation.
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Loss of TRPC1 in adipocytes reduces SOCE
Since TRPC1 is an active member of SOCE mechanisms and is highly
expressed in adipocytes, we explored whether TRPC1 is vital to adipocyte
differentiation. To do this, SVF cells from TRPC1-/- and WT mice were isolated and
differentiated. Analysis by Ca2+ imaging of both Subc AT cell types (SVF and
differentiated adipocytes) showed TRPC1-/- cells had a reduction in internal ER
Ca2+ release (first peak) with the addition of Tg as compared to WT (Figure 14 AD). When 1mM external Ca2+ was added, [Ca2+]i in both SVF and differentiated
TRPC1-/- cells was significantly reduced as compared to WT indicating diminished
SOCE in TRPC1-/- cells. The TRPC1-like membrane current observed in WT Subc
SVF adipocytes upon the addition of Tg (1mM) was significantly reduced in Subc
AT SVF from TRPC1-/- mice (Figure 14 E-G). Similar results were observed in
differentiated Subc AT, where loss of TRPC1 significantly decreased Tg-mediated
Ca2+ currents (Figure 14 H-J).
To confirm that lack of TRPC1 alters SOCE mechanisms in differentiated
Sub AT, we depleted internal stores through treatment with angiotensin II, which
stimulates endogenous G-protein coupled receptors. Addition of angiotensin II
resulted in a decrease of Ca2+ entry in TRPC1-/- differentiated Subc AT indicating
that TRPC1 is the functional store/receptor-operated Ca2+ entry (S/ROCE) channel
in these cells (Figure 15 A, B). Importantly, basal Ca2+ entry (no store depletion)
was unaltered in adipocytes from WT or TRPC1-/- mice (Figure 15 C, D).
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Figure 14 Loss of TRPC1 in adipocytes reduces SOCE
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TR PC1-/-

Figure 14 Loss of TRPC1 in adipocytes reduces SOCE
Fura-2 traces and quantification of transient increase in [Ca2+]i after addition of
1 μM Tg and 1 mM Ca2+ to WT and TRPC1-/- Subc AT SVF (A, B) and
differentiated Subc AT (C, D). Application of 1 μM Tg induced inward currents
at −80mV in WT Control and TRPC1-/- Subc AT SVF (E) and differentiated Subc
AT (H). Respective IV curves of Subc AT SVF (F) and differentiated Subc AT
(I). Quantification (n = 5 recordings) of current intensity at −80 mV is shown for
Subc AT SVF in (G) and differentiated Subc AT in (J). Graphs are mean ± SEM,
significance: *, p < 0.05; **, p < 0.01.
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Figure 15 Angiotensin II treatment of differentiated Subc AT
Analog plots of Ca2+ entry upon addition of angiotensin II in a Ca2+ containing
media from an average of 30-50 cells isolated from WT or TRPC-/- mice are
shown in B. Quantification (mean ± S.D.) of 340/380 ratio under these
conditions is shown in B. Basal Ca2+ entry (without store-depletion) from an
average of 40-50 cells in each condition are shown in C. (D) Quantification
(mean ± S.D.) of 340/380 ratio. significance: *, p < 0.05; ***, p < 0.001.
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TRPC1
TRPC1

Next, isolated VAT from WT and TRPC1-/- mice was evaluated in the same
manner as the Subc AT experiments. Electrophysiological recordings of
membrane currents indicate TRPC1 currents were significantly reduced in both
VAT SVF TRPC1-/- cells (Figure 16 A-C) and differentiated TRPC1-/- VAT (Figure
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Figure 16 SOCE currents in visceral adipocytes reduced
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C1-/-

Application of 1 μM Tg induced inward currents at −80mV in WT Control and
TRPC1-/- VAT SVF cells (A) and differentiated VAT (D). Respective IV curves
for each cell type are shown for VAT SVF (B) and differentiated VAT (E).
Quantitation (n = 5 recordings) of current intensity at −80 mV for VAT SVF (C)
and differentiated VAT (F). Graphs are mean ± SEM, significance: *, p < 0.05.
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Figure 17 Ca2+ channel
expression of WT and
TRPC1-/- Subc AT and VAT
Western

blot

of

TRPC5,

TRPC3, STIM1, ORAI3, and
ORAI1 protein expression of
WT and TRPC1-/- Subc AT
and VAT tissue lysates.

16 D-F). Interestingly, after differentiation, the Ca2+ current in TRPC1-/- VAT was
more inwardly rectifying and showed properties similar to ORAI1 currents. Analysis
of Ca2+ influx upon treatment with Tg showed a decrease in internal ER Ca2+
release in TRPC1-/- differentiated VAT adipocytes but not in undifferentiated VAT
SVF (Error! Reference source not found. A-D). Similar to Subc AT, addition of
external Ca2+ resulted in a reduction in Ca2+ influx in both types (SVF and
differentiated) of TRPC1-/- VAT as compared to WT control (Error! Reference
source not found. A-D). Combined data from Subc AT and VAT indicates SOCE
mechanisms in SVF and differentiated adipocytes from both depots are impaired
due to the loss of TRPC1.
Protein expression analysis of numerous Ca2+ regulating proteins in WT and
TRPC1-/- Subc AT and VAT was performed to rule out compensation for the lack
of TRPC1. As shown in Figure 18, an increase in STIM1 and TRPC5 expression
was observed in Subc AT of TRPC1-/- mice which is consistent with our previous
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work (Krout et al., 2017). However, no significant change in either STIM1 or
TRPC5 was observed in VAT. It is known that TRPC1 forms a C1/C5
heterotetramer with TRPC5 (Shi et al., 2012), however loss of TRPC1 would make
TRPC5 inactive and thus not compensate for the loss of TRPC1 in TRPC1-/- mice.
Interestingly, increasing STIM1 expression has been shown to have no effect on
normal SOCE mechanisms (Gwozdz et al., 2012). The remaining Ca2+ channels,
TRPC3, ORAI1, and ORAI3, showed no change in protein expression between
WT and TRPC1-/- in either tissue type (Figure 18). This indicates the lack of TRPC1
function in adipose tissue most likely does not increase Ca2+ entry by altering
protein expression of other Ca2+ channels.

Lack of TRPC1 mediated Ca2+ influx reduces ability to differentiate
We next investigated whether a lack of TRPC1 would alter the ability of
Subc and VAT SVF cells to differentiate. Analysis of lipid accumulation via oil-redo in WT and TRPC1-/- adipocytes after seven days of differentiation revealed a
significant reduction in total lipid when TRPC1 is nonfunctional in Subc AT (Figure
19 A, B) and VAT (Figure 19 C, D). This same phenomenon is replicated in the
protein expression of perilipin, FABP4, and PPARg which were also reduced in
TRPC1-/- Subc AT (Figure 20 A, B) and VAT (Figure 20 C, D) as compared to WT.
To offset the reduced ability to increase [Ca2+]i of TRPC1-/- cells, Subc AT and VAT
SVF cells from WT and TRPC1-/- mice were differentiated with a 2 and 4 fold
greater extracellular Ca2+ concentration than basal. In WT and TRPC1-/- Subc AT
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cells, increasing extracellular Ca2+ to both 2 and 4 fold produced no change in lipid
accumulation (Figure 19 A, B). No difference in lipid accumulation was observed
when extracellular Ca2+ concentrations were increased in TRPC1-/- VAT, however
WT VAT adipocytes differentiated with a 4 fold greater extracellular Ca2+
concentration had significantly less lipid than basal (Figure 19 C, D). We next
assessed whether the reduction in lipid accumulation due to increased
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extracellular Ca2+ was replicated in adipogenetic protein expression. In WT Subc
AT there was a significant reduction in expression of PPARg and perilipin when
extracellular Ca2+ concentration was raised to 4-fold, however the expression of
FABP4 did not seem to be altered in either tissue type (Figure 20 A, B). Raising
extracellular Ca2+ concentrations in TRPC1-/- Subc AT and VAT had similar results
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Figure 18 Loss of TRPC1 in adipocytes reduces ability to differentiate
Oil-red-o staining of WT and TRPC1-/- Subc AT (A) and VAT (C) differentiated in
1x (basal), 2x, or 4x extracellular Ca2+ for 7 days. Quantification of eluted oil-redo stain at 492nm of Subc AT (B) and VAT (D). Graphs are mean ± SEM,
significance: *, p < 0.05; **, p < 0.01.
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to WT with the greatest expression observed at basal for PPARg and perilipin.
Together these results reveal TRPC1 to be a functional partner in SOCE in both
Subc AT and VAT differentiation and may necessary for the early stages of
differentiation to promote PPARg expression. Further, reduced Ca2+ influx due to
loss of TRPC1 cannot be supplemented by raising extracellular Ca2+
concentrations. Finally, increased extracellular Ca2+ concentrations diminish lipid
accumulation and PPARg expression in WT Subc AT and VAT, however no
substantive change was observed in FABP4 expression.
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Figure 19 Adipogenetic protein expression in TRPC1-/- adipocytes
diminished
Western blot of PPARg, FAPB4, and perilipin protein expression of WT and
TRPC1-/- Subc AT (A) and VAT (B) differentiated in 1x (basal), 2x, or 4x
extracellular Ca2+.
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TRPC1-/- mice have increased fatty-acid desaturation index
and adiposity with age
We have determined that lack of TRPC1 leads to a reduction in lipid
accumulation and differentiation in an ex vivo model, leading us to next investigate
whether dysfunctional TRPC1 channels could alter overall body composition. Body
mass composition analysis was performed on TRPC1-/- and WT mice aged 13-15
months, which resulted in a more than two-fold increase in the ratio of total fat to
body weight in TRPC1-/- mice as compared to age matched WT mice (Figure 21
A). Visually this difference in body composition can be seen in Figure 21 B where
9-month-old TRPC1-/- mice have increased Subc AT and VAT volume as
compared to its WT counterpart. Interestingly, the increase in total fat observed in
TRPC1-/- mice did not translate to an increase in their overall body weight. Within
a majority of age groups, no significant difference in the overall body weight was
observed in TRPC1-/- mice when compared with WT mice, however younger
TRPC1-/- mice, aged 0-3 months, had reduced overall body weight (Figure 21 C).
In all ages, TRPC1-/- mice did have lower organ weights (such as hearts and
kidneys), which were reduced in size regardless of age and may attribute to the
increase in adiposity without an increase in overall body weight (Figure 21 D).

58

Figure 20 TRPC1-\- mice have increased adiposity with age
(A) Body fat mass measured by EchoMRI and calculated by dividing the fat
weight by total body weight of mice aged 13-15 months n=9-11. (B) Exposed
Subc AT and Visc AT of WT and TRPC1-/- male mice aged 9 months. (C) Total
body weight of WT and TRPC1-/- mice grouped by 3-month increments of age.
(D) Ratio of organ to total body weight of WT and TRPC1-/- mice. Graphs are
mean ± SEM, significance: *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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Obesity is most easily characterized by excess adipose accumulation,
however excess lipids are also stored in other organs such as the liver, muscle,
and pancreas. To determine whether the increased adiposity observed in TRPC1/-

mice effected important metabolic organs, fatty acid composition of liver samples

from WT and TRPC1-/- mice was calculated using gas chromatography/mass
spectrometry (GC/MS). Liver fatty acid composition was relatively the same
between WT and TRPC1-/- samples with the exception of mono and
polyunsaturated fatty acids which were increased in TRPC1-/- (Figure 22 A). These
included palmitoleic acid (16:1), oleic acid (18:1), linoleic acid (18:2), eicosenoic
acid (20:1), and eicosadienoic acid (20:2). Increased ratios of monounsaturated to
saturated fatty acids (desaturation index), particularly palmitoleic to palmitic acid
(16:1/16:0) and oleic to stearic acid (18:1/18:0), has been correlated to obesity and
insulin resistance (Jeyakumar et al., 2009; Pinnamaneni et al., 2006; Yee et al.,
2014). Within our study, we found that both ratios were increased in liver samples
from TRPC1-/- mice (Figure 22 B), indicating increased activity of Stearoyl CoA
desaturase 1. Together these data suggest that the loss of TRPC1 function
attributes to an increase in the accumulation of adipocytes, but not overall weight,
and a liver lipid profile similar to an obese phenotype.
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Figure 21 Desaturation of liver fatty acids increased in TRPC1-/- mice
Composition of liver fatty acids of WT and TRPC1-/- mice aged 4 months
determined by gas chromatography/mass spectrometry (GC/MS) n=5. (B) Fatty
acid desaturation index (16:1/16:0 and 18:1/18:0) calculated from (A). Graphs
are mean ± SEM, significance: *, p < 0.05.
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Conclusion
The incidence of obesity-associated diseases such as type II diabetes,
hypertension, cardiovascular risk, and cancer has increased drastically worldwide.
Consequently, scientific inquiry into the mechanisms underlying adipose tissue
development and the pathology of obesity has gained interest. Though an array of
metabolic disorders are linked to alterations of Ca2+ homeostasis (Arruda and
Hotamisligil, 2015), the study of Ca2+ within adipose tissue has been
underrepresented. Evidence suggests adipose tissue [Ca2+]i is partly mediated by
SOCE (El Hachmane et al., 2018), thus we focused on the identification of the
endogenous Ca2+ entry channel and establish its role in adipocyte function. In our
study, we identify TRPC1 as a major regulator of adipocyte energy metabolism
through mediation of adipocyte differentiation.
SOCE was first identified as a major component of non-excitable cells
(Parekh and Putney, 2005), but further research has identified SOCE within a
multitude of tissue types. This knowledge has unveiled it to be a ubiquitous Ca2+
signaling pathway which regulates numerous cellular functions including those
connected with diabetic complications (Chaudhari and Ma, 2016). Identification of
SOCE mechanisms within adipocytes may lead to a better understanding of the
onset of obesity and metabolic disorders and reveal therapeutic possibilities.
Within our study, Ca2+ entry was demonstrated to have SOCE properties that could
effectively be reduced by the addition of a non-specific Ca2+ entry channel blocker
SKF in both Subc AT and VAT. This indicates a similar mechanism for Ca2+ entry
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influx between the tissue types. Furthermore, the current properties observed and
blocked by SKF were similar to that of a TRPC1 channel (Liu et al., 2003; Selvaraj
et al., 2012). The role of SOCE and the specific Ca2+ channel involved within Subc
AT and VAT was further confirmed using adipose tissue with a genetic ablation of
TRPC1. Loss of TRPC1 showed a significant decrease in Ca2+ entry upon
treatment with Tg in SVF and differentiated adipocytes of both tissue types.
Importantly, although ORAI1 was present, it was not able to compensate for the
loss of TRPC1, suggesting that the major Ca2+ entry channel in adipocytes is
mediated via TRPC1. Interestingly, loss of ORAI1 has been shown to modulate
immune function (Ahuja et al., 2017), which also plays a vital role in obesity. Within
our study, TRPC5 expression is increased upon adipocyte differentiation; however
as TRPC1 forms C1/C5 heterotetramers (Shi et al., 2012), loss of TRPC1 would
inactivate TRPC5 and thus could not compensate in TRPC1-/- mice. Upon
differentiation, a higher amplitude of TRPC1-like current in both Subc AT and VAT
was observed which is most likely attributable to the more than 2-fold upregulation
of TRPC1 expression. In addition, current properties in differentiated VAT cells,
especially in TRPC1-/-, were similar to that observed with ORAI1. This suggests
that ORAI1 could play a role in VAT tissues, however further research is needed
to fully establish the role of ORAI1 in these cells.
Adipocyte differentiation is a complex process and dysregulation can lead
to lipid accumulation and altered energy and metabolic regulation. Though the
process is not fully understood, several studies have identified Ca2+ dependency
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within adipocyte differentiation (Jensen et al., 2004; Neal and Clipstone, 2002;
Pramme-Steinwachs et al., 2017; Shi et al., 2000). Our study is the first to use both
genetic and pharmacological inhibitors to show that Ca2+ entry via TRPC1 is critical
for adipocyte differentiation. Our results are consistent with other studies that have
identified modulators such as STIM1 expression changes (Graham et al., 2009)
and calcineurin, a calcium and calmodulin dependent serine/threonine protein
phosphatase, activation (Neal and Clipstone, 2002) as important for the maturation
of adipocyte precursor cells. Use of SKF to block store-mediated Ca2+ entry during
differentiation not only impaired lipid droplet formation in WT Subc AT and VAT
SVF, but also inhibited the expression of lipid mobilization proteins FABP4 and
perilipin and transcription factor PPARg.
The transcription factor PPARg is essentially expressed during early
differentiation stages and regulates a number of adipocyte marker genes, including
FABP4 and perilipin (Farmer, 2006; Wu et al., 1999). Here we show blockage of
Ca2+ influx by SKF suppresses PPARg expression indicating Subc AT and VAT
SVF may be unable to induce the initial processes of differentiation when SOCE
is inhibited. Suppression of SOCE by TRPC1 loss, as seen in TRPC1-/- Subc and
VAT cells, resulted in a reduction but not a complete impairment of lipid
accumulation in both tissue types. Correspondingly, TRPC1-/- Subc and VAT
differentiated adipocyte expression of FABP4, perilipin, and PPARg was reduced
when compared to WT indicating TRPC1 may be involved in the initial stages of
PPARg mediated differentiation. In the next chapter, we will discuss adipocyte size
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more, however it was found that TRPC1-/- had a lower quantity of large adipocytes
in Subc AT and VAT as compared to WT which may be attributed to partial
differentiation dysfunction.
In contrast to Ca2+ blockage, continuous exposure to high external Ca2+ has
been shown to inhibit preadipocyte differentiation (Jensen et al., 2004) and block
adipocyte lipid accumulation and expression of adipogenic transcription factors
(Pramme-Steinwachs et al., 2017; Shi et al., 2000). The relationship between
serum and extracellular Ca2+ is tightly regulated and kept at relatively similar
concentrations (Hofer and Brown, 2003). Interestingly, increased serum Ca2+ has
been associated with obesity (Ren et al., 2013) and type II diabetes (Lorenzo et
al., 2014) and could denote a correlative increased extracellular Ca2+
concentration.

Within

our

study,

increasing

normal

extracellular

Ca2+

concentrations by 4-fold decreased differentiation in WT VAT but had no effect on
Subc AT. Interestingly, a slight difference in lipid accumulation was observed
between WT Subc AT and WT VAT at all Ca2+ concentrations. Subc AT is known
to have greater differentiation potential and proliferative ability when compared to
VAT (Baglioni et al., 2012), which most likely explains the differences observed in
WT Subc and VAT lipid accumulations. Subc AT was able to overcome the
inhibitory effect of the increased extracellular Ca2+ to sustain lipid accumulation,
whereas VAT adipocytes were not. Though increasing extracellular Ca2+
concentrations had no effect on lipid accumulation in Subc AT, protein expression
of key differentiation factors reduced when Ca2+ increased which is similar to that
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of VAT. This may confirm what other studies have shown that extended exposure
to high Ca2+ concentrations inhibits differentiation of adipocytes, particularly in
VAT.
Impaired adipogenesis can lead to a multitude of different outcomes with
the most common being an unhealthy expansion of adipose tissue. This
phenomenon is generally seen in adult obesity which is hypertrophic in nature and
the reason why PPARg agonists such as TZDs are useful in obesity (Choe et al.,
2016). Interestingly, hypertrophic adipocytes from obese mice were observed to
have increased Ca2+ deposits surrounding lipid droplets possibly indicating
increased [Ca2+]i (Giordano et al., 2013). Within our study, TRPC1-/- mice exhibited
increased adipose tissue accumulation as they aged; however overall body weight
did not significantly increase relative to WT mice. This increase in adipose
accumulation could be due to dysfunctional adipose differentiation which in time
results in a hypertrophic expansion. Another important finding was that organ
weights were reduced, which could be due to the fact that TRPC1 has been shown
to play a critical role in cell proliferation (Alonso-Carbajo et al., 2017) and may be
a reason for the increase in adipose accumulation without an increase in body
weight.
Though differentiation may contribute to the increased adiposity, there
could be other explanations including a reduction of lipolysis. If this is the case,
fatty acids are not mobilized from triacylglycerol stores properly, which in turn
would expand adipose tissue volume over time. Furthermore, deletion of FABP4
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has been shown to reduce lipolysis and FABP4 knockout mice have increased
white AT mass on a high-fat diet (Hotamisligil et al., 1996). In our model, lack of
TRPC1 may inhibit the expression FABP4 thus reducing lipolysis. Another
possibility is that TRPC1 could be involved in store-operated Ca2+ entry necessary
to induce lipolysis. Lack of store-operated Ca2+ entry proteins have shown to
disrupt regulators of lipid metabolism and results in increased organ lipid droplet
formation (Maus et al., 2017). Together, these results indicate that SOCE via
TRPC1 may be involved in the initial stages of adipocyte differentiation of both
Subc AT and VAT and result in increased adipose tissue volume over time,
however more research needs to be done to determine the exact mechanism.
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CHAPTER IV
THE TRPC1 Ca2+-PERMEABLE CHANNEL INHIBITS
EXERCISE-INDUCED PROTECTION AGAINST HIGH-FAT DIET-INDUCED
OBESITY AND TYPE II DIABETES

Introduction
Obesity is a hallmark of metabolic syndrome and a key feature of obesity is
the disruption of metabolic homeostasis leading to excess adipose accumulation
(Blüher, 2009; Claycombe et al., 2013; Claycombe et al., 2016; Claycombe et al.,
2015), thus therapeutic targeting of proteins involved in these pathways could be
essential for slowing or preventing the development of obesity and obesity-related
health problems, including insulin resistance and type II diabetes. As shown in
Chapter one along with other reports (Sukumar et al., 2012), TRPC1 gene
expression is induced in differentiated adipocytes, yet no data are currently
available on whether TRPC1 has a role in adipocyte energy metabolism regulation
by altering mitochondrial energy oxidation, adipocyte lipid storage and size, and
adipose tissue weight.
A possible way that TRPC channels may control energy metabolism and
adiposity is by acting as sensors for chemical factors necessary in adipocyte
biology (Sukumar et al., 2012). Dietary saturated fat intake promotes obesity and
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type II diabetes (Holzer et al., 2011) whereas n-3 polyunsaturated fatty acids
(PUFAs) mainly found in fish oil produce opposite effects (Kuda et al., 2016;
Ouguerram et al., 2006). Treatment of human embryonic kidney cells (HEK 293)
with n-3 PUFAs such as linolenicdocosahexaenoic, and eicosapentaenoic acids
inhibit Ca+2 entry via TRPC5 homomeric and TRPC1–TRPC heteromeric
channels. Interestingly, the PUFA concentrations used in this study were within the
physiologically achievable range of the human diet (Sukumar et al., 2012).
Whether high dietary saturated fat intake modulates adipocyte energy metabolism
via TRPC1-mediated signaling is not yet known.
Moreover, experimental evidence indicates that several TRP channels play
an important role in the onset of diabetes (Graham et al., 2009; Hu et al., 2009;
Sabourin et al., 2015) or diet-induced obesity (Ye et al., 2012); however, the role
of TRPC1 in these circumstances is not yet established. Exercise regulates body
energy stores and insulin resistance by reducing adipocyte size and lipid content
(Craig et al., 1981; Gollisch et al., 2009) and by regulating serum glucose
homeostasis through inducing GLUT4 (glucose transporter type 4) protein
expression (Stanford et al., 2015). Interestingly, treadmill running prevents Ca+2
dysregulation and diabetic dyslipidemia in high-fat (HF) fed swine (Witczak et al.,
2006). TRPC1 knock-out (KO or TRPC1-/-) mice with attenuated Ca+2 entry (Liu et
al., 2007) experienced reduced muscular endurance due in part to reduced force
production and a greater rate of muscle fatigue (Zanou et al., 2010). However,
whether a HF diet could exacerbate reduced exercise tolerance in TRPC1 KO mice
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or contribute to mitochondrial energy metabolism dysfunction is also not yet
known. Currently, no other studies have investigated the effects of dietary HF and
exercise on adipocyte energy metabolism alteration via TRPC1 protein regulation
of intracellular Ca+2 homeostasis.
The regulation of adipocyte size and longevity may also be an area of
involvement for TRPC1. It has been shown that increased subcutaneous adipocyte
size is predictive to the development of insulin resistance and type II diabetes
(Lundgren et al., 2007; Skurk et al., 2007; Weyer et al., 2000). Further, there is a
negative correlation between adipocyte size and insulin sensitivity and a positive
correlation with proinflammatory adipocytokine secretion (Lönn et al., 2010; Yang
et al., 2012). It has also been reported that adipose mass along with differentiation
is regulated by a process called autophagy (Singh et al., 2009; Zhang et al., 2009).
Interestingly, there is an increase in autophagy in obese subjects, particularly in
VAT depots (Kovsan et al., 2011) along with an increase in apoptotic pathways
(Alkhouri et al., 2010; Sorisky et al., 2000). Autophagy deficient mice exhibit
reduced efficiency in adipogenesis (Baerga et al., 2009) with altered morphology
(Wang and Peng, 2012).
Autophagy is described as a cellular process responsible for the delivery of
proteins or organelles to lysosomes for degradation. Cells encountering stressful
situations can either try to survive using the beneficial process of autophagy or by
activating a programmed cell death program called apoptosis (Decuypere et al.,
2011; East and Campanella, 2013; Kondratskyi et al., 2013). To date, three types
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of autophagy exist; macroautophagy, microautophagy and chaperone-mediated
autophagy (CMA) (Decuypere et al., 2011; Kato et al., 2014). Cellular stress
conditions including nutrient starvation, hypoxia conditions, invading microbes,
and tumor formation have been shown to induce autophagy and allows cell survival
in these stressful or pathological situations (Kato et al., 2014). In addition,
autophagy also recycles existing cytoplasmic components that are required to
sustain vital cellular functions (Zhang and Calderwood, 2011). Although autophagy
and apoptosis are mechanistically different cellular processes, there are some
common regulatory proteins that intervene in both, such as the anti-apoptotic/antiautophagy regulators B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma-X large (BclXL) and Ca2+ signaling. Bcl-2 and Bcl-XL are known to inhibit apoptosis by binding
to Bcl-2–associated X (Bax) or Bcl-2 homologous antagonist/killer (Bak) but also
suppress autophagy by binding to Beclin-1 (Lindqvist et al., 2014).
Intracellular Ca2+ is known to play an important role in autophagy in both
basal and induced models (Cárdenas et al., 2010; Høyer-Hansen et al., 2007),
however the mechanism by which Ca2+ regulates autophagy remains controversial
(Decuypere et al., 2011). This is due to the previous studies showing both an
activating and inhibitory role in autophagy (Cárdenas et al., 2010; Su et al., 2013).
A commonality to these different studies is the focus on IP3R which is important
for SOCE mechanisms (Figure 23). With regards to channel identity, our laboratory
has shown in numerous studies indicating TRPC1 has a role in cell survival and
apoptosis (Bollimuntha et al., 2006; Pani et al., 2006; Selvaraj et al., 2009).
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Recently our lab has shown that TRPC1 is a key regulator in hypoxia and nutrient
depletion dependent autophagy (Sukumaran et al., 2015). Specifically, that an
increase in intracellular Ca2+ via TRPC1 regulates autophagy, thereby preventing
cell death in two morphologically distinct cells lines (Sukumaran et al., 2016).
The present study investigated the involvement of TRPC1 in diet-induced
obesity and type II diabetes. Additionally, regulation of adipocyte formation under
normal-fat (Stanford et al., 2015) or HF diet and control cage or voluntary exercise
conditions was also evaluated to determine how optimal dietary treatments and
exercise promote a healthy body weight. Our data indicate that TRPC1 KO mice
fed a HF diet and exercised are protected from diet-induced obesity and type II
diabetes risk due to decreased autophagy and increased apoptosis resulting from
loss of Ca+2 influx through TRPC1.
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Figure 22 Role of intracellular Ca2+ and Ca2+ permeable channels in
autophagy
Schematic diagram showing intracellular Ca2+ and Ca2+ permeable channels
in the control of autophagy. Stimulation of Ca2+ permeable channels are
activated both excited and non-excited Ca2+ channels and results in release of
the store Ca2+ from the ER and Golgi bodies. These results in ER stress and
disturbed Ca2+ homeostasis in the cells; which via various Ca2+ regulated
proteins like ERK, calpains, cAMP regulates the autophagy processes.
Reprinted from “Functional role of TRP channels in modulating ER stress and
Autophagy” by P. Sukumaran, 2016, Cell Calcium, 60, 123-132. Copyright
2016 by Elsevier. Reprinted with permission.
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Results

Body fat mass is decreased in TRPC1 KO mice fed a HF diet and exercised
For 12 weeks, mice were fed diets containing either 16% (normal-fat, NF)
or 45% fat (high-fat, HF) for 12 weeks and subjected to voluntary wheel running
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Figure 23 TRPC1 KO mice fed a HF diet and exercised have decreased
body fat mass
A and B, body weight was measured at week 0 (A) and week 12 (B). C, body
weight change was calculated by dividing the body weight at week 12 by the body
weight at week 0. D and E, body fat mass was measured by EchoMRI at week 0
(D) and week 12 (E). F, body fat change was calculated by dividing the fat weight
at week 12 by the fat weight at week 0. Data are presented as mean ± S.D., n =
6–8. Significant (p < 0.05) effects from 3-way ANOVA are indicated by + (mouse
type), × (diet), and # (exercise).
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exercise. TRPC1 KO mice had lower body weight (Figure 24 A) and body fat mass
(Figure 24 D) at the start of the study and after 12 weeks of diet and exercise
(Figure 24 B, E) when compared to WT mice. However, when calculated as a fold
change, there was no change in body weight when comparing WT to TRPC1 KO
mice (Figure 24 C). Within groups, change in body fat mass was significantly
decreased in TRPC1 KO mice fed a HF diet and exercised compared to WT mice
fed a HF diet and exercised (Figure 24 F). Furthermore, TRPC1 KO mice fed a HF
diet and exercised had less change in body fat mass than TRPC1 KO mice fed a
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Figure 24 Daily food intake and exercise is unaltered
Food consumption and exercise were measured biweekly from WT and TRPC1
KO mice over the course of 12 weeks. Data are presented as means ± S.D., n =
7-8. Significant (p < 0.05) effects from 3-way ANOVA are indicated by + (mouse
type), × (diet), and # (exercise).
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HF diet and subjected to sedentary cage activity (Figure 24 F). Though food intake
variation was influenced by the type of mouse and an exercise x diet interaction,
altered body composition was not a result of group differences in food consumption
or exercise (Figure 25 A, B). As we saw from the data presented in Chapter One,
TRPC1 is the major Ca2+ entry channel in adipocytes and the new data presented
here shows that loss of TRPC1 decreases obesity risk in HF fed mice that exercise.
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Figure 25 TRPC1 KO mice fed a HF diet and exercised have reduced insulin
resistance
A–D, blood glucose (A and B), plasma insulin (C), and calculated homeostatic
model assessment of insulin resistance (D) were measured from WT and TRPC1
KO mice fasted overnight after 12 weeks of diet and exercise. Data are presented
as mean ± S.E. (A) or S.D. (B–D), n = 7–8. Significant (p < 0.05) effects from 3way ANOVA are indicated by + (mouse type), × (diet), and # (exercise).
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TRPC1 KO mice fed a HF diet and exercised are protected
from type II diabetes risk
The data provided above show an important role for TRPC1 in the onset of
metabolic syndrome. Thus, glucose concentrations were next evaluated under
these conditions. Maximum blood glucose concentrations occurred 15-30 min after
intraperitoneal injection of glucose in all groups (Figure 26 A). Interestingly, overall
TRPC1 KO mice had reduced blood glucose concentrations as compared to WT,
however, within groups, blood glucose concentrations were only decreased in
TRPC1 KO mice fed a HF diet and exercised when compared to WT mice fed a
HF diet and exercised (Figure 26 B). Similarly, serum insulin concentrations were
overall decreased in TRPC1 KO mice and the group TRPC1 fed a HF diet and
exercised was decreased as compared to WT mice fed a HF diet and exercised
(Figure 26 C). Using a homeostatic model assessment of insulin resistance
(HOMA IR) to assess the fasting blood glucose/insulin ratio, we found that, once
more, TRPC1 KO mice were overall less insulin resistant than WT and the TRPC1
KO group fed a HF diet and exercised were less insulin resistant than WT mice fed
a HF diet and exercised (Figure 26 D). It was confirmed that this difference was
not due to altered expression of GLUT4 in the subcutaneous adipose tissue
(Figure 27 A) or skeletal muscle (Figure 27 B). These studies suggest that loss of
TRPC1 decreases insulin resistance and risk of diabetes thereby inhibiting
metabolic syndrome.
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Figure 26 GLUT4 expression is unaltered in Subc AT and skeletal
muscle
A and B, GLUT4 expression in subcutaneous adipose tissue (A) and hind
leg biceps femoris skeletal muscle (B) was measured from WT and TRPC1
KO mice following 12 weeks of diet and exercise. Data are presented as
mean ± S.D., n = 7–8.
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Adipocyte numbers are decreased in
TRPC1 KO mice fed a HF diet and exercised
To establish if adipocyte number or size is varied under these conditions,
we counted the number of adipocytes present in adipose tissue depots and
determined the adipocyte size. In the subcutaneous and visceral adipose tissue
depots, adipocytes with size ranges of 80-160 μm were decreased in TRPC1 KO
mice fed a HF diet and exercised compared to WT mice fed a HF diet and
exercised but not in the smaller size range of 20-80 μm (Figure 28). In addition,
TRPC1 KO mice fed a HF diet and subjected to sedentary cage activity had
decreased adipocytes from 160-200 μm when compared to WT mice fed a HF diet
and subjected to sedentary cage activity (Figure 28) This data suggests that loss
of TRPC1 combined with a HF diet decreases the number of larger adipocytes,
which could explain the decreased fat mass observed in Figure 24.
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Figure 27 TRPC1 KO mice fed a HF diet and exercised have fewer
adipocytes
Adipose tissue harvested from WT and TRPC1 KO mice following 12 weeks of
diet and exercise was measured by a Multisizer. Data are presented as mean
± S.D., n = 6–8. Significant (p < 0.05) effects from 3-way ANOVA are indicated
by + (mouse type), × (diet), and # (exercise).
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Autophagy marker expression is decreased while apoptosis marker
expression is increased in TRPC1 KO mice fed a HF diet and exercised
To determine whether reduced adipocyte numbers in adipose depots of
TRPC1 KO mice fed a HF diet and exercised seen in Figure 28 were due to
apoptosis or reduced differentiation of adipocytes, we measured mRNA of key
markers for adipogenesis (PPARγ), beiging (FGF21), hypoxia (HIF1α), and
autophagy (MAP1LC3A, BECN1). Though there was no altered mRNA expression
of PPARγ, FGF21, HIF1α, or BECN1 in subcutaneous adipose tissue (Figure 30
A-D), expression of the autophagy marker MAP1LC3A was decreased (as
indicated by an increased Ct value) in TRPC1 KO mice fed a HF diet and exercised
compared to WT mice fed a HF diet and exercised (Figure 29 A). To confirm that
our mRNA expression was replicated on the protein level, we examined protein
expression of autophagy (LC3A, p62) and apoptosis (Bax, Bcl-xl) regulating
proteins in WT and KO mice fed a HF diet and exercised. LC3A expression was
decreased along with an increase in p62 expression in samples from TRPC1 KO
mice that were fed a HF diet and exercised when compared with WT mice fed a
HF diet and exercised indicating a deficiency in autophagy (Figure 30 B, C).
Conversely, increased expression of Bax and an increased Bax to Bcl-xl ratio,
which is an indication of increased apoptosis, was observed in the TRPC1 KO
mice fed a HF diet and exercised compared to WT mice fed a HF diet and
exercised (Figure 29 B-D). Together, these results suggest that loss of TRPC1
decreases autophagy, a survival mechanism, and increases apoptosis, which
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could promote loss of larger adipocytes. In addition, loss of TRPC1 significantly
decreased phosphorylation of ERK2, whereas no change in the phosphorylation
of ERK1 and AMPK was observed (Figure 31). These data further indicate that
loss of TRPC1 inhibits ERK2 phosphorylation, which has been shown to interact
with ATG proteins and thus could modulate autophagy in these cells.
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Figure 28 Autophagy marker expression is decreased whereas apoptosis
marker expression is increased in TRPC1 KO mice fed a HF diet and exercised
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MAP1LC3A mRNA expression was measured from subc adipose tissue taken

from WT and TRPC1 KO mice following 12 weeks of diet and exercise. Data are
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presented as mean ± S.D., n = 6–8. B, subc adipose tissue from WT and TRPC1
KO mice fed a HF diet and exercised was resolved and analyzed by Western
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blotting using antibodies labeled in the figure. Quantification of each protein is
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shown in C. Data are presented as mean ± S.D., n = 7–11. D, ratio of Bax/Bcl-xl is
presented as a fold increase of TRPC1 KO over WT values.
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Figure 29 Expression of markers for adipogenesis, beiging, and
hypoxia were unaltered in subcutaneous adipose tissue
mRNA expression of PPARγ (adipogenesis) (A), FGF21 (beiging) (B),
HIFIα (hypoxia) (C), and BECN1 (autophagy) (D) was measured from
subcutaneous adipose tissue taken from WT and TRPC1 KO mice
following 12 weeks of diet and exercise. Data are presented as means ±
S.D., n = 6-8.
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Conclusion
This study is the first to show that TRPC1 KO mice that exercise are
protected from HF diet-induced obesity and type II diabetes risk due to decreased
adipose tissue mass and adipocyte number as a result of reduced autophagy and
increased apoptosis. Thus, in combination, exercise, HF diet, and loss of TRPC1
reduce adiposity through a yet undefined mechanism. Given that TRPC1 is
involved in Ca2+ entry following depletion of internal Ca2+ stores in the ER, TRPC1
KO results in decreased Ca2+ entry in a variety of cell types including adipocytes
(Sukumar et al., 2012), skeletal muscle (Zanou et al., 2010), neuronal (Fiorio Pla
et al., 2005), intestinal epithelial cells (Rao et al., 2006), and salivary glands (Liu
et al., 2007; Liu et al., 2000). Thus, based on our data, it is probable that reduced
Ca2+ entry due to TRPC1 KO is influenced further by HF diet and exercise,
suggestive of a relationship between Ca2+ entry, diet, and exercise. Although
expression of Orai1 and STIM1 was observed in adipocytes, the properties of the
endogenous channel was similar to that observed with TRPC1-mediated ISOC (Liu
et al., 2007; Liu et al., 2000) and not as observed with ICRAC channels (Peinelt et
al., 2006; Yuan et al., 2009). Similarly, the increased expression of TRPC5 in
adipocytes did not alter Ca2+ influx as current-voltage recordings were distinctly
different from TRPC5 homologs and TRPC1/TRPC5 heteromeric channels would
be non-functional due to the loss of TRPC1 function (Strübing et al., 2001; Wu et
al., 2010). Furthermore, TRPC1 KO mice showed exercise-mediated inhibition of
adiposity and decreased insulin resistance in the absence of TRPC1 suggesting
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that TRPC1 might be the dominant Ca2+ channel in these cells. However, additional
studies will be needed to determine the role of Orai1 channels in exercisemediated regulation of metabolic syndrome.
The present study demonstrated that fat mass was reduced in TRPC1 KO
mice compared to WT mice following twelve weeks of HF diet and exercise.
Similarly, previous studies have shown that TRPV4 KO mice (another Ca2+ entry
channel from the TRPV family) are also protected from obesity and metabolic
dysfunction with exposure to HF diet (Ye et al., 2012) suggesting that Ca2+
channels negatively regulate obesity. This is in contrast to the expectations that
HF-fed mice develop obesity and glucose intolerance (Kalupahana et al., 2010)
since TRPC1 KO mice fed a HF-diet and exercised were less insulin resistant than
their WT counterpart, indicative of protection from type II diabetes risk, yet GLUT4
expression was unaltered in hind leg biceps femoris skeletal muscle or
subcutaneous adipose tissue. Furthermore, the number and size of subcutaneous
and visceral adipocytes are decreased in TRPC1 KO mice compared to WT mice
when fed a HF diet and exercised. Because TRPC1 plays a key role in cell survival
and apoptosis (Bollimuntha et al., 2006; Pani et al., 2006; Selvaraj et al., 2009), it
was hypothesized that TRPC1 KO mice would alter expression patterns of key
markers for adipogenesis, apoptosis, or autophagy in subcutaneous adipose
tissue. TRPC1 KO mice fed a HF diet and exercised had decreased expression of
the autophagy marker MAP1LC3A and increased p62 expression along with an
increase in apoptosis markers (particularly the ratio of Bax/Bcl-xl). This is in
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agreement with our previous findings that silencing of TRPC1 decreased
autophagy and increased cell death (Sukumaran et al., 2015). Loss of TRPC1 also
decreased phosphorylation of ERK2, which is consistent with previous studies
where activation of Ca2+ channels in adipocytes increased ERK2 phosphorylation
(Ye et al., 2012). In addition, loss of TRPC1 decreased the number of larger
adipocytes. These findings suggest that elimination of TRPC1-mediated Ca2+ entry
in TRPC1 KO mice promotes suppression of autophagy in HF diet-fed and
exercised mice resulting in increased adipocyte cell death. These results are
consistent with previous studies where patients with metabolic syndrome also have
higher serum Ca2+ levels (Saltevo et al., 2011; Sorva and Tilvis, 1990), which could
be due to the loss of TRPC1 or other Ca2+ channels that mediate Ca2+ entry in
adipocyte cells, thereby increasing serum Ca2+ levels. Interestingly, in skeletal
muscle, even though contraction does not depend on extracellular Ca2+ (Armstrong
et al., 1972), Ca2+ entry through TRPC1 is essential for maintaining force during
sustained repeated contractions. TRPC1 KO mice experience muscle fatigue
during endurance exercise though spontaneous wheel running activity is
unchanged (Zanou et al., 2010). Our data is in agreement as we showed no
alteration in voluntary exercise. However, a reduction in endurance exercise might
be expected because loss of TRPC1 could impact mitochondrial respiration by
altering Ca2+ homeostasis, due to an increase in total mitochondrial protein
stimulated by exercise training (Holloszy, 1967; Scalzo et al., 2014), and Ca2+ is
needed for proper functioning of mitochondria (Chan et al., 2009). In addition, ER
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stress resulting from reduced Ca2+ entry could increase translocation of apoptotic
factors into mitochondria thus permeabilizing the membrane, causing release of
cytochrome c and activation of caspases, leading to mitochondrial-mediated cell
death (Budihardjo et al., 1999; Pan et al., 2001; Selvaraj et al., 2009; Wei et al.,
2001). These findings demonstrate that loss of TRPC1 disrupts Ca2+ homeostasis
potentially resulting in mitochondrial-mediated cell death of adipocytes. Although
a previous study has shown that knockdown of TRPC1 only attenuated nonstimulated Ca2+ influx in breast cancer cells (Davis et al., 2012), our results using
adipocytes did not show any decrease in basal Ca2+ entry. These results suggest
that while in breast cancer cells other Ca2+ influx channels (Orai1) might be more
important for SOCE, TRPC1 is essential for adipocyte function, especially in
blocking the effects of exercise in HF diet-induced obesity. The mechanism by
which TRPC1 KO mice fed a HF diet and exercised are protected from obesity and
type II diabetes risk needs further investigation. However, our study and another
published study (Ye et al., 2012) indicate that loss of Ca2+ might be the main factor
that inhibits the formation of metabolic syndrome.
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CHAPTER V
TRPC1 TRANSPORTS Ca2+ INVOLVED IN SNARE COMPLEX FORMATION
DURING ADIPONECTIN SECRETION

Introduction
Adipose tissue was initially considered to be an inert fat storage depot until
the discovery of linkages between obesity and inflammation. Currently, adipose
tissue is considered a complex endocrine organ secreting over 600 bioactive
factors (Lehr et al., 2012; MacDougald and Burant, 2007), termed adipokines.
These adipokines influence diverse physiological processes by relaying
information to other metabolically active organs such as muscle, liver, pancreas,
and brain, thereby modulating systemic metabolism (Ouchi et al., 2011).
Importantly, increased adipose accumulation, as seen in obesity, correlates to
dysregulation of adipokine secretion (Arita et al., 1999; Matsuzawa, 2010; Maury
and Brichard, 2010) and increases susceptibility to other diseases (Rasouli and
Kern, 2008). Altering levels of the adipokines, mainly adiponectin (Fruebis et al.,
2001; Okada-Iwabu et al., 2013) and leptin (Stern et al., 2016), have shown to
improve energy homeostasis and offset diet-induced obesity. Thus, adipokines
have potential to be therapeutic targets to combat/counter or reduce obesity and
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other metabolic diseases, however, a full understanding of the mechanisms and
intracellular mediators that modulate adipokine secretion within adipose tissue is
first required.
Adiponectin is a cytokine primarily secreted from mature adipocytes,
however it has been shown to be expressed in other tissues including human and
murine osteoblasts, liver, myocytes, epithelial cells, and placental tissue (Achari
and Jain, 2017). Adiponectin is known to have an anti-inflammatory effect as it
inhibits the expression of vascular adhesion molecules, scavenger receptors, is an
antagonist of toll like receptors (TLR) and their ligands, and pro-inflammatory
cytokines TNFα, IL-6 and IL-1β in various tissues types (Fantuzzi, 2013; Tsatsanis
et al., 2005; Turer and Scherer, 2012). Anti-oxidant properties have also been
attributed to adiponectin which are mediated by the cyclic AMP/protein kinase A
pathway (Ebrahimi-Mamaeghani et al., 2015; Scherer et al., 1995; Yamauchi and
Kadowaki, 2013). Adiponectin has garnered interest as a metabolic therapeutic
due to its positive effect on lipid and glucose metabolism in kidney, liver and
muscle. Utilizing the AMPK pathway, adiponectin is known to increase fatty acid
oxidation, mitochondria biogenesis, and insulin sensitivity (Achari and Jain, 2017;
Komai et al., 2014).
Adiponectin is one of the most abundant circulating cytokine accounting for
roughly 0.01% of total serum protein (Villarreal-Molina and Antuna-Puente, 2012).
Normal human serum adiponectin concentrations are 3 to 30 µg/mL (Ouchi et al.,
2003), however concentrations have been found to be negatively correlated to
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Figure 31 Adiponectin synthesis
Schematic representation of the steps involved in the production and secretion of
adiponectin. Monomeric adiponectin (mAd) is the initial form and posttranslationally modified and oligomerized into trimers (low molecular weight,
LMW), hexamers (medium, MMW) and oligomeric (high, HMW) forms. Reprinted
from “Adiponectin action: A combination of endocrine and autocrine/paracrine
effects” K. Dadson, 2011, Frontiers in Endorcinology, 2011;2-62. Copyright 2011
by Frontiers Media SA. Reprinted with permission.

obesity and positively correlated to insulin sensitivity (Achari and Jain, 2017;
Kadowaki et al., 2006; Kovacova et al., 2012). Decreases in blood concentrations
during obesity have been attributed to disturbances in both production and
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secretion of adiponectin from adipose tissue (Hoffstedt et al., 2004; Kovacova et
al., 2012; Liu and Liu, 2009). Interestingly, mice fed a high-fat diet and treated with
a synthetic small-molecule adiponectin receptor (AdipoRon) agonist ameliorated
insulin resistance and glucose intolerance (Okada-Iwabu et al., 2013). Moreover,
treatment with this synthetic adiponectin inhibited the onset of diabetes in
genetically obese rodent model db/db mice further highlighting the prospect of
using adiponectin as a therapeutic target for metabolic disorders.
Adiponectin is initially synthesized as a monomeric pre-hormone (Figure
32), then oligomerized into three isoforms and packaged in vesicles until
stimulated for release (Dadson et al., 2011). Expression is transcriptionally
regulated by the transcription factors C/EBPs, sterol regulatory element binding
protein 1c (SREBP1c), and nuclear receptor peroxisome proliferator-activated
receptors γ (PPARγ) which is induced by the thiazolidinedione (TZD) family of
drugs (Dadson et al., 2011; Liu and Liu, 2009; Yamauchi and Kadowaki, 2013).
Adiponectin is first formed as a 30 kDa monomer that is assembled within the ER
into complex isoforms such as high (HMW 300 kDa), medium (MMW 140 kDa),
and low (LMW 67 kDa) molecular weights (Figure 32). The HMW isoform is thought
to be the most biologically active and Ca2+ has been implicated as important for its
formation (Banga et al., 2008; Rosen and Spiegelman, 2014). Interestingly, the
ratio of plasma HMW adiponectin to total adiponectin appears to be a stronger
indicator of insulin resistance than measuring total adiponectin levels alone due to
its high correlation with glucose and insulin levels (Lara-Castro et al., 2006).
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Release of adiponectin from adipocytes has been shown to be insulin and
Ca2+ dependent (Bogan and Lodish, 1999; Cong et al., 2007; Komai et al., 2014;
Xie et al., 2008) and a high-Ca2+ diet has been shown to stimulate the expression
of adipokines along with inhibition of pro-inflammatory factors (Sun and Zemel,
2007). The mechanism of secretion is mediated by golgi-localized, gamma adaptin
ear-containing, ARF-binding protein 1 (GGA1)-coated vesicles originating at the
Golgi with exocytosis being regulated through protein kinase A (PKA)-independent
cAMP stimulation in both a Ca2+ dependent and independent process (Komai et
al., 2014; Xie et al., 2008). Though Ca2+ dependency has been shown in
adiponectin exocytosis, the specific Ca2+ channel involved has yet to be
determined. We’ve shown in previous chapters the high expression and
importance of TRPC1 in adipocyte function, thus TRPC1 could likely be involved
in the Ca2+ dependent mode of adiponectin secretion (Baboota et al., 2014; Bishnoi
et al., 2013; Sukumar et al., 2012).
Regulated exocytosis in adipocytes mediates key functions, exemplified by
insulin-stimulated secretion of peptides such as adiponectin and recycling of
intracellular membranes containing GLUT4 glucose transporters to the cell surface
(Bogan and Lodish, 1999). Plasma membrane synaptosomal-associated protein
25 (SNAP-25) and syntaxin-1, termed t-SNAREs, and secretory vesicleassociated protein 2 (VAMP-2 or v-SNARE), are part of the conserved protein
complex involved in the fusion of opposing membranes necessary for exocytosis
(Söllner et al., 1993; Trimble et al., 1988; Zhang et al., 2016) (Figure 33). An
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important feature of each of these proteins is a stretch of heptad repeats, termed
SNARE motifs, which serve as co-binding locations (Fasshauer et al., 1998;
Weimbs et al., 1997). Syntaxin-1 and VAMP-2 each contain a single SNARE motif
while SNAP-25 contains two. During the initial stage of exocytosis, the vesicle
approaches the PM and VAMP-2, syntaxin-1, and SNAP25 interact with each other
via SNARE motifs to form quaternary bundles of a-helices called SNARE
complexes. It has been well demonstrated that Ca2+ provides the final event
needed for vesicle fusion and release of its content, however channel specificity is
still elusive (Di Giovanni et al., 2010; Südhof and Rothman, 2009). Our laboratory
has shown an interaction between VAMP-2 and TRPC3 in neuronal and epithelial
cells was necessary for exocytosis (Singh et al., 2004). Interestingly, there is data
implying an interaction between SNAP-25 and TRPC1 in human platelets during
TRPC1 trafficking (Redondo et al., 2004) which could suggest a more involved role
for the two proteins in SNARE complex formation.
As shown in Chapter 2, TRPC1-/- adipose tissue has reduce SOCE function
and differentiation leading us to investigate whether other adipose functions are
impaired. Ca2+ has been shown in numerous studies to be involved in the secretion
of adipokines from adipose tissue (Komai et al., 2014; Sukumar et al., 2012; Ye et
al., 2010), however the Ca2+ channel(s) involved have not been identified. The aim
of this study was to identify the endogenous Ca2+ entry channel in adipocytes
necessary for adipokine production and secretion. We report that loss of TRPC1
function reduces serum adiponectin concentrations in TRPC1-/- mice due to
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impaired exocytosis of adiponectin from adipocytes. We further show TRPC1mediated Ca2+ is necessary for SNARE complex formation necessary for
adiponectin loaded vesicle fusion.

Figure 32 SNARE complex formation
Assembly of SNARE complex formation depicting the steps involved with vesicle
fusion and exocytosis. (I) monomeric t-SNAREs SNAP-25 and syntaxin located
on the PM, (II) partial assembly of t-SNARE complex, (III) the folded t-SNARE
complex and introduction of vesicle associated proteins synaptotagamin and
VAMP2 along with Munc-18, (IV) activated SNARE complex, (V) partially
zippered trans-SNARE complex, (VI) introduction of Ca2+ completes the zippered
SNARE complex and exocytosis occurs. Reprinted from “Single-molecule study
of t-SNARE complex” by X. Zhang, 2016, Proceedings of the National Academy
of Sciences, 113(50) E8031-E8040. Copyright 2016 by Proceedings of the
National Academy of Science. Reprinted with permission.
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Results

Serum adipokines levels are reduced in TRPC1-/- mice
To determine whether the reduction in Ca2+ influx in TRPC1-/- adipose tissue
alters adipokine levels, we assessed serum adiponectin and leptin concentrations
of WT and TRPC1-/- mice. Elisa assessed serum concentrations of both
adiponectin and leptin were significantly reduced in TRPC1-/- mice as compared to
their WT counterpart (Figure 34 A, B), whereas no change in food intake was
observed (Figure 25). Adiponectin and leptin are almost entirely produced by
adipocytes which led us to question whether the reduction in serum concentrations
seen in TRPC1-/- mice was due to a decrease in overall production. To assess this,

Figure 33 Serum adipokines are altered in TRPC1-/- mice.
Elisa assessed total serum APN (A) and leptin (B) of WT and TRPC1-/- mice
aged 3-9 months, APN n=6, leptin n=8. Graphs are mean ± SEM,
significance: *, p < 0.05
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Subc AT and VAT lysates from WT and TRPC1-/- mice were evaluated for
adiponectin and leptin protein expression. No difference was observed in either
adiponectin or leptin expression between adipose tissue obtained from TRPC1-/or their WT counter parts indicating loss of serum concentrations is most likely not

Figure 34 No difference in leptin and adiponectin concentrations within
adipose tissue
Western blot and quantification of leptin and adiponectin protein expression
normalized to actin of WT and TRPC1-/- tissue lysates of Subc AT and VAT and
quantified.
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due to a malfunction in production (Figure 35). Interestingly, both WT and TRPC1/-

VAT samples contained higher levels of both adiponectin and leptin than Subc

AT samples possibly indicating VAT may play a larger role as a distributor of
adipokines. These results suggest that reduced serum adiponectin and leptin
concentrations in TRPC1-/- mice are not likely a consequence of lower adipose
tissue production.

Exercise recovers diminished serum
adiponectin concentrations in TRPC1-/- mice
Exercise is known to increase circulating adiponectin concentrations
(Kriketos et al., 2004; Lee et al., 2011; Wang et al., 2015), however there are
conflicting views on the effect of a high-fat diet on serum adiponectin
concentrations (Barnea et al., 2006; Bullen et al., 2007). This lead us to investigate
whether a high-fat diet and exercise would alter serum adipokine concentrations
in TRPC1-/- mice. WT and TRPC1-/- mice were placed on a diet of either normalchow (16% fat) or high-fat (45% fat) diet for 12 weeks and subjected to voluntary
wheel running exercise. At the end of the 12 weeks, serum adiponectin
concentrations were assessed. Within WT groups, adiponectin concentrations
were increased in sedentary WT mice fed a high-fat diet and in exercised WT mice
fed a normal-chow diet as compared to WT sedentary mice fed a high-fat diet,
however, the combination of high-fat diet and exercise had no effect on adiponectin
concentrations (Figure 36). Similar to Figure 34, sedentary TRPC1-/- mice feed a
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normal-chow diet had significantly reduced adiponectin concentrations as
compared to their WT counterparts which was replicated in sedentary TRPC1-/mice feed a high-fat diet indicating the increase in adiponectin due to high-fat diet
is impaired in TRPC1-/- mice. Notably, reduced adiponectin concentrations in
TRPC1-/- mice fed either normal-chow diet or high-fat diet was offset by the addition

Figure 35 Reduced serum adiponectin concentrations in TRPC1-/- mice
recovered when exercised
Total serum adiponectin from WT and TRPC1-/- mice fasted overnight after 12
weeks on normal-chow (16% fat) or high-fat (45% fat), n=8 mice. Normal-chow
(NF), High-fat (HF). Significant (p < 0.05) effects from 3-way ANOVA are
indicated by + (mouse type), × (diet), and # (exercise). Graphs are mean ± SEM,
significance: *, p < 0.05; **, p < 0.01.; ***, p < 0.001.
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Figure 36 Serum adiponectin isoforms altered in TRPC1-/- mice
Serum adiponectin isoforms (A) assessed by non-denaturing PAGE. Optical
density of each isoform (HMW (high molecular weight), MMW (middle
molecular weight), LMW (low molecular weight)) normalized to total protein
from respective Ponceau S stains and quantified (B). (C) Non-denaturing
PAGE of Subc AT and VAT protein tissue lysates and quantified. Graphs are
mean ± SEM, significance: *, p < 0.05; **, p < 0.01.
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of exercise. Overall this indicates that serum adiponectin concentrations in TRPC1/-

mice are affected by the addition of exercise, but a high-fat diet results in no

change.

Adiponectin isoforms are altered in TRPC1-/- mice
The isoform composition of total serum adiponectin has been shown to be
important to overall health assessment due to its correlation with glucose and
insulin levels (Lara-Castro et al., 2006), thus we assessed the composition of
serum samples from Figure 34. Evaluation of serum adiponectin from WT and
TRPC1-/- mice by non-denaturing gel electrophoresis indicated a significant
reduction in both HMW and MMW isoforms with no difference in LMW (Figure 37
A, B). To understand whether the reduction of HMW and MMW isoforms in TRPC1/-

mouse serum is due to an issue in adiponectin production and folding within

adipose tissue, Subc AT and VAT adiponectin isoform composition was assessed.
In all three isoforms, there was no difference observed between WT and TRPC1-/in either Subc AT or VAT indicating isoform assembly is not a likely candidate for
differences in serum levels (Figure 37 C). Within these studies, we observed
TRPC1-/- mouse serum contains significantly less of the biologically active form of
adiponectin (HMW) than WT mice, which does not correspond to intracellular
tissue quantities.
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Diminished adiponectin secretion in Subc AT from TRPC1-/- mice
Secretion of adiponectin from adipose tissue can be triggered by insulin
(Bogan and Lodish, 1999; Cong et al., 2007). To mimic this process ex vivo, fresh
Subc AT and VAT from WT and TRPC1-/- mice was cut into 8-15 mg pieces,
suspended in media, and stimulated with insulin (100 nM) for 6 hours. The media
was then examined via ELISA and normalized to mg of tissue to determine total
adiponectin concentrations. Upon insulin stimulation, secreted adiponectin
concentrations from WT Subc AT were significantly increased compared to nontreated control (Figure 38 A). Importantly, treatment of TRPC1-/- Subc AT with

A

B

S u b c u ta n e o u s

V is c e r a l
A d ip o n e c tin S e c r e tio n

A d ip o n e c tin S e c r e tio n

*

*

2 .0

n g /m L /m g

2 .0

n g /m L /m g

NS

2 .5

2 .5

1 .5
1 .0

1 .5
1 .0
0 .5

0 .5

0 .0

0 .0
C o n tro l

In s u lin

WT

C o n tro l

C o n tro l

In s u lin

TRPC1

-/-

In s u lin

WT

C o n tro l

In s u lin

TRPC1

-/-

Figure 37 Insulin stimulated secretion diminished in TRPC1-/- Subc AT
Elisa assessed adiponectin secreted from Subc AT (A) and VAT (B) samples
in 8-15 mg pieces from WT and TRPC1-/- stimulated with insulin (100 nM) for
6 hours, n=9. Concentration of adiponectin normalized to tissue size (mg).
Graphs are mean ± SEM, significance: *, p < 0.05.
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insulin did not result in a significant increase in adiponectin secretion as seen in
the WT Subc AT, but was significantly lower that WT Subc AT stimulated with
insulin (Figure 38 A). Interestingly, insulin stimulation of VAT from both WT and
TRPC1-/- mice did not result in a significant increase in adiponectin secretion
(Figure 38 B), however all VAT samples secreted roughly 2-fold more adiponectin
than Subc AT samples. This could be attributed to the increased endogenous
levels seen in VAT (Figure 35) and possibly indicate non-stimulated secretion from
VAT is higher than Subc AT.
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Figure 38 Distribution of adiponectin isoforms from secretion samples
Analysis of adiponectin isoforms from Figure 37 assessed by non-denaturing
PAGE. Optical density of each isoform (HMW (high molecular weight), MMW
(middle molecular weight), LMW (low molecular weight)) is shown as a
percentage of total adiponectin for each lane. No significance was
determined for all samples.
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Analysis of adiponectin isoforms upon insulin stimulation showed a slight
increase in MMW secretion in Subc AT from both WT and TRPC1-/-, however no
significance was determined. Overall the distribution of adiponectin isoforms was
similar in all tissue types and animals (Figure 38). This data indicates adipocytes
with TRPC1 deficiency have a reduced response to insulin–stimulated secretion
of adiponectin, but it does not affect the overall distribution of isoforms secreted.

Reduced SNARE protein interactions in TRPC1-/- adipose tissue
Our lab has shown that a functional interaction between SNARE family
proteins and Ca2+ influx is required for intracellular vesicle fusion (Singh et al.,
2004), thus we investigated whether impairment of adiponectin secretion may be
due to diminished SNARE interactions due to TRPC1 loss. VAMP-2 is found within
the plasma membrane of intracellular vesicles and is involved in the docking of the
vesicles to the plasma membrane by interacting with plasma membrane SNARE
proteins, such as syntaxin-1 and SNAP 25. To assess whether TRPC1 may be
involved in SNARE complex formation needed to exocytose adipokine vesicles
from adipose tissue, co-immunoprecipitation was performed on fresh adipose
samples. Subc AT and VAT were isolated from WT and TRPC1-/- mice,
homogenized, quantified, and incubated with insulin (100 nM), SKF (10 mM), or
Tg (1 mM) for 30 min. In this model, insulin treatment mimics the initial stages of
adiponectin secretion (as seen in Figure 38) and SKF treatment was used to
determine whether blocking store-mediated Ca2+ influx channels would reduce
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insulin-induced SNARE interactions. As shown in Figure 40, plasma membrane
SNARE components syntaxin-1 and SNAP-25 co-immunoprecipitated with
VAMP2 in both WT and TRPC1-/- control samples. Upon treatment with insulin, the
interaction of VAMP-2 with syntaxin-1 and SNAP-25 increased in WT samples,
however no change was observed in TRPC1-/- samples. Pretreatment with SKF
prior to insulin did not alter interactions of SNAP-25 with VAMP-2 in WT adipose
tissue, however it did reduce interactions of VAMP-2 with syntaxin-1. Treatment of
TRPC1-/- adipose tissue cells with SKF had no effect on interactions of either
syntaxin-1 or SNAP-25 with VAMP-2. Raising [Ca2+]i and initiating SOCE through
treatment with Tg increased SNAP-25 and VAMP-2 interactions in WT adipose
tissue, however it did not result in a change in WT VAMP-2 and syntaxin-1
interactions. Further, no variation in interactions between VAMP-2 and SNAP-25
or syntaxin-1 was observed upon treatment with Tg within TRPC1-/- adipose tissue
indicating depletion of the ER and initiation of SOCE mechanisms is not enough
to overcome the loss of TRPC1. Together these results indicate insulin stimulated
SNARE complex formation in adipose tissue involves TRPC1-mediated Ca2+ entry,
which is needed for exocytosis of adiponectin.
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Figure 39 Reduced SNARE protein interactions in TRPC1-/- adipose tissue
Co-immunoprecipitation assay of SNARE complex proteins in combined Subc
AT and VAT tissue lysates from WT and TRPC1-/- upon stimulation with insulin
(100 nM), SKF (20 μM), or Tg (2 μM). Western blot analysis was performed using
anti-Vamp2 antibody and immunoprecipitating with anti-SNAP25 (A,C) and antiSyntaxin-1 (B,D) antibodies. Graphs are mean ± SEM, significance: *, p < 0.05;
**, p < 0.01.
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Conclusion
Reduced secretion of adiponectin resulting in low serum concentrations is
a common feature of obesity (Kovacova et al., 2012), whereas low serum leptin
can be used as an indicator of malnutrition (Amirkalali et al., 2010). TRPC1-/- mice
present both reduced serum adiponectin and leptin concentrations, however
TRPC1-/- mice do not display either of these phenotypes. Food consumption and
weight measurements of TRPC1-/- mice were similar to WT throughout their lifetime
(Figure 25), however as we saw previously (Figure 21), as TRPC1-/- mice age, their
volume of adipose deposits increases. This increase in adiposity later in life is
could be attributed to decreased differentiation as discussed in Chapter III or to
suppressed adiponectin secretion which lowers overall body metabolism.
Importantly, equal concentrations of adiponectin and leptin were observed within
the Subc AT and VAT samples of WT and TRPC1-/- mice, which is contrary to the
reduced serum concentrations in TRPC1-/- mice (Figure 35). This indicates that
there is no reduction in adipokine production, but rather the release of adipokines
is affected in TRPC1-/- mice.
When challenging both WT and TRPC1-/- mice with a high-fat diet and
exercise for 12 weeks, we observed an increase in total serum adiponectin
concentrations in sedentary WT mice feed a high-fat diet and exercised WT mice
on a normal-chow. It has been well established that exercise increases circulating
adiponectin concentrations (Kriketos et al., 2004; Lee et al., 2011; Wang et al.,
2015), however the effect of a high-fat diet on serum adiponectin is still debated.
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Differing studies have shown both increases and decreases in serum adiponectin
concentrations when mice are fed a high-fat diet (Barnea et al., 2006; Bullen et al.,
2007; Chaolu et al., 2011) and may be reflective of acute versus long-term feeding.
This discrepancy in results after high-fat feeding may explain why WT mice feed a
high-fat diet and exercised did not display an increase in adiponectin
concentrations as compared to sedentary WT mice on a normal-chow diet.
Importantly, the results of the 12 week study confirmed our previous result that
sedentary TRPC1-/- mice on a normal-chow diet have significantly decreased
serum adiponectin concentrations and as we saw in Figure 24, sedentary TRPC1/-

mice fed normal-chow did not display a difference in overall body weight or fat

mass as compared to WT. This indicates reduced serum adiponectin
concentrations in TRPC1-/- mice is not a result of increased adiposity further
indicating a dysfunction in adiponectin secretion. It is also notable that the high-fat
diet had no effect on sedentary TRPC1-/- mice, however the addition of exercise
did result in differences in both TRPC1-/- mice feed a high-fat and normal-chow
diet.
Exercise is thought to increase circulating adiponectin concentrations
through a multitude of processes including increased expression of adiponectin
receptors in muscle (Tsuchida et al., 2004; Zeng et al., 2007), increased secretion
of adiponectin from muscle through PPARy activation (Amin et al., 2010), and
release of adiponectin from adipose tissue due to exercise induced fat mass loss
(Wang et al., 2015). The theory that increased serum adiponectin is due to release
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of adiponectin stores from exercise induced fat mass loss is most likely not
occurring in our study as the only animal that had reduced weight and fat mass
was TRPC1-/- mice that were fed a high-fat diet and exercised (Figure 24). If this
theory was correct, we would expect the increased serum adiponectin
concentrations in exercised WT mice on normal-chow to be correlated to a
decrease in fat mass, which was not seen. The more probable explanation would
be increases in either adiponectin receptors or secretion from muscle, which could
compensate for the reduced adiponectin secretion from adipose tissue due to
TRPC1 loss.
Interestingly, it has been found that the greatest reduction in serum
adiponectin in obese subjects is from Subc AT and the metabolically active isoform
HMW (Kovacova et al., 2012). Analysis of serum adiponectin isoforms in our study
indicates a similar reduction in HMW with the addition of MMW, however internal
adipose tissue concentrations of adiponectin were similar between WT and
TRPC1-/-. This reduction in TRPC1-/- serum HMW isoform is most likely due to
increased utilization by downstream targets, such as muscle and liver, since
overall abundance is diminished. However, due to the lack of understanding of the
purpose and distribution of adiponectin isoforms, more investigation is needed.
The dependence on Ca2+ for the secretion of adipokines has been shown in
numerous studies (Bogan and Lodish, 1999; El Hachmane et al., 2018; Komai et
al., 2014; Levy et al., 2000; Sukumar et al., 2012; Ye et al., 2010), however the
Ca2+ channel(s) involved have not been identified. The most extensive work has
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shown that cAMP stimulates exocytosis of adiponectin-containing vesicles in a
Ca2+ dependent and independent manner (Komai et al., 2014), but no channel
specificity was determined. Within the study by Sukumar et al., alterations in
adiponectin secretion due to blockage of TRPC1 and TRPC5 in differentiated 3T3L1 adipose cells through use of antibodies and siRNA was investigated. Contrary
to our findings, their results showed an increase in adiponectin in the extracellular
media indicating increased secretion, however no measurement of changes in
internal adiponectin production, basal internal concentrations, or agonist mediated
release were determined. Also, the 3T3-L1 cell line originates from a single clone,
resulting in a cell line incomparable to the characteristics of primary cell culture
models (Ruiz-Ojeda et al., 2016). Because of this, we do not feel the 3T3-L1 cell
line is a precise model of the in vivo state, thus we believe our usage of primary
cell lines from SVF and ex vivo tissue stimulation is a more accurate
representation.
It has been well documented that regulated exocytotic events including the
fusion of intracellular organelles such as synaptic vesicles, secretory
vesicles/granules, or lysosomes with the plasma membrane are Ca2+-dependent
(Reddy et al., 2001; Royle and Murrell-Lagnado, 2003). In particular, TRPC
channels have been implicated in the GPR40 signaling pathway of glucosestimulated insulin secretion in pancreatic beta-cell (Yamada et al., 2016). Within
secretory pathways, it has been suggested that increases in [Ca2+]i is needed in
the vicinity of organelles (Barclay et al., 2005; Burgoyne and Clague, 2003), thus
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our lab began investigation into the recruitment of Ca2+ channels to the site of
fusion. Our lab previously demonstrated a functionally significant interaction
between TRPC3 and SNARE proteins involved in intracellular vesicles fusion
(Singh et al., 2004). Within this study, TRPC3 was observed to colocalize and coimmunoprecipitate with VAMP-2 in neuronal cells, thus we theorized that this
phenomenon may not be isolated to TRPC3. Utilizing this theory, we investigated
whether TRPC1 may be important for SNARE complex formation adipocytes. To
understand the mechanisms as to how TRPC1 regulates adipokine secretion, we
stimulated fresh homogenized WT and TRPC1-/- adipose tissue with various
agents and measured the interactions of VAMP-2 with SNAP-25 and syntaxin-1.
Insulin stimulation induced the secretion of adiponectin and increased interactions
of VAMP-2 with both SNAP-25 and syntaxin-1 in WT adipose tissue indicating a
possible mechanistic action for adiponectin secretion. Treatment of adipocytes
with Tg has shown both an increase and a decrease in adiponectin secretion in a
time dependent manner (Torre-Villalvazo et al., 2018), thus we explored whether
short term treatment with Tg would alter SNARE interactions. As seen in Figure
40, a 30 min treatment with Tg increased VAMP-2 and SNAP-25 interactions only
in WT adipose tissue. Interestingly, neither insulin or Tg resulted in changes in
VAMP-2 interactions with either SNAP-25 and syntaxin-1 within TRPC1-/- adipose
tissue which indicates a role for TRPC1 in insulin stimulated vesicle fusion. We
believe these results provide enough evidence to state that insulin stimulated
TRPC1 mediated Ca2+ influx is involved in fusion of VAMP-2 with SNAP25 and
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syntaxin1, thus necessary for proper secretion of adipokines. Overall, our results
provide evidence that TRPC1 not only plays a key role in adipocytes differentiation,
but is essential for adipokine secretion, and dysfunction in these vital processes
could lead to obesity and metabolic syndrome.
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CHAPTER VI
LOSS OF TRPC1 IS LIKELY NOT THE CAUSE OF
REDUCED ADIPONECTIN SIGNALING IN SKELETAL MUSCLE

Introduction
As discussed in Chapter V, adiponectin is known to regulate lipid
metabolism and mitochondrial biogenesis in a number of target organs including
muscle and liver (Achari and Jain, 2017). The effects of adiponectin are mediated
in these tissues primarily via the action of two plasma membrane bound atypical
seven-transmembrane domain receptors, named AdipoR1 and AdipoR2
(Yamauchi et al., 2003) (Figure 41). Both receptors contain an intracellular Ntermini and extracellular C-termini and are significantly homologous with 67%
amino acid identity (Kadowaki et al., 2006). AdipoR1 is ubiquitously expressed with
the highest abundance in skeletal muscle, while AdipoR2 is predominantly
expressed in the liver (Wang et al., 2009; Yamauchi and Kadowaki, 2013).
Differences between AdipoR1 and AdipoR2 have been identified in binding
properties (Yamauchi et al., 2003), cell surface expression (Heiker et al., 2010;
Keshvari et al., 2017), and temporal signaling profiles (Keshvari and Whitehead,
2015). Interestingly, a deficiency in AdipoR1, AdipoR2, or both receptors produced
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Figure 40 Adiponectin signaling through AdipoR1 and AdipoR2
Adiponectin has three known receptors of AdipoR1, AdipoR2, and T-cadherin (T-cad).
AdipoR1/2 can interact with adaptor protein containing pleckstrin homology domain,
phosphotyrosine-binding domain, and leucine zipper motif (APPL1). AdipoR1 increases
Ca2+ influx to activate Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) and
subsequent downstream kinases. Ca2+/calmodulin-dependent protein kinase (CaMK) and
AMP-activated protein kinase (AMPK) can increase peroxisome proliferator-activated
receptor (PPAR) gamma coactivator 1 alpha (PGC-1α) mRNA expression thereby
increasing mitochondrial biogenesis and fatty acid oxidation. AdipoR1 activates liver kinase
B1 (LKB1) and AMPK. AdipoR2 is predominantly expressed in the liver and can activate
PPARα to increase FA oxidation and insulin sensitivity. Reprinted from “The multifaceted
and controversial immunometabolic actions of adiponectin” by S. Esmaili, 2014, Trends in
Endocrinology and Metabolism, 25(9), 444-451. Copyright 2014 by Elsevier. Reprinted with
permission.
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glucose intolerance in a diet-induced obesity mouse model (Yamauchi et al.,
2007), while muscle-specific AdipoR1-KO mice also display metabolic dysfunction
(Iwabu et al., 2010). Overexpression of AdipoR1 in rat skeletal muscle has been
shown to improve insulin resistance and promote glucose uptake (Patel et al.,
2012). Recently, overexpression of AdipoR1 or AdipoR2 in mouse tibialis anterior
muscle increased adiponectin signaling, however the effects were diminished in
obese mice despite no reduction in circulating adiponectin levels (Keshvari et al.,
2017). The overexpression of AdipoR1 or AdipoR2 had no effect on circulating
adiponectin concentrations, however, knockouts of the receptors had differing
phenotypes. Mice deficient of AdipoR1 had increased fat mass, decreased glucose
tolerance, and no change in plasma adiponectin concentrations while AdipoR2
deficient mice were lean, had improved glucose tolerance, and increased plasma
adiponectin concentrations (Bjursell et al., 2007). Much is still to be understood
about adiponectin signaling, but evidence suggests the receptors AdipoR1 and
AdipoR2 may play differing roles.
Another adiponectin-binding partner is T-cadherin which has been identified
in C2C12 myoblasts and skeletal muscle. Though T-cadherin has a high binding
affinity for hexameric and HMW forms (Hug et al., 2004), it is not thought to have
the same receptor properties as AdipoR1 and AdipoR2 as T-cadherin does not
contain an intracellular domain. Interestingly, deficiency of T-cadherin in mice
leads to a major upregulation of circulating adiponectin levels indicating some sort
of role in adiponectin signaling (Williams et al., 2012).
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Bound to both AdipoR1 and AdipoR2 is adaptor protein containing
pleckstrin homology domain, phosphor-tyrosine domain, and leucine zipper
domain 1 (APPL1) which is known to positively modulate adiponectin signaling
(Figure 41). Specifically, suppression of APPL1 reduces adiponectin signaling
while overexpression increases downstream events (Cheng et al., 2007; Mao et
al., 2006). The downstream targets of AdipoR1 and AdipoR2 are contrasting and
result in different outcomes. AdipoR1, through APPL1, is known to promote AMPactivated protein kinase (AMPK) activation and a subsequent increase in
expression of master regulator peroxisome proliferator-activated receptor γ
coactivator-1α (PGC-1α), whereas AdipoR2 mediates activation of peroxisome
proliferator-activated receptor alpha (PPARα), both of which are involved in fatty
acid oxidation (Jäger et al., 2007; Yamauchi et al., 2007). Another interesting
difference between AdipoR1 and AdipoR2, is the involvement in Ca2+ influx in
AdipoR1 signaling. Iwabu et al., 2010 showed that adiponectin binding to AdipoR1
induces a Ca2+ influx, which activates Ca2+/calmodulin-dependent protein kinase
kinase β (CaMKKβ) and subsequent AMPK. Within this study, downregulation of
AdipoR1 by siRNA reduced the influx of Ca2+ and chelating Ca2+ with EGTA
reduced phosphorylation of AMPK. Though there is strong evidence to suggest
that Ca2+ is a component of the adiponectin signaling pathway, no work has been
done to determine the channel responsible for its influx.
It has been demonstrated that SOCE partially contributes to the Ca2+ supply
necessary for the maintenance of skeletal muscle contraction, however it has been
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determined that it is not required for the initiation of muscle contraction (Cho et al.,
2017; Stiber et al., 2008). In skeletal muscle, SOCE is modulated much faster than
non-excitable cells with activation occurring within a second whereas nonexcitable cells require tens of seconds (Nakipova et al., 2017). The fast kinetics of
skeletal muscle SOCE is likely due to the pre-coupling of STIM1 to ORAI1
(Dirksen, 2009; Stiber et al., 2008). Very little has been investigated regarding
TRPC1 involvement in SOCE within skeletal muscle, but TRPCs have been shown
to have important roles in skeletal muscle in other ways. In particular, TRPC1 has
been shown to be important for skeletal muscle migration and differentiation (Louis
et al., 2008; Zanou et al., 2012). Further, skeletal muscles from TRPC1−/− mice
display smaller myofibre cross-sectional areas resulting in reduced contractional
force over time (Zanou et al., 2010).
Within this study, we investigate the involvement of TRPC1 in adiponectin
signaling pathway in muscle to determine whether loss of TRPC1 has an effect on
downstream targets and upstream adiponectin serum concentrations due to failed
signaling. We report that SOCE mechanisms are exhibited in both C2C12 muscle
cell line and primary Extensor Digitorum Longus (EDL) muscle. Additionally,
activation of AdipoR1 with the agonist AdipoRon results in an influx of Ca2+ which
can be blocked by SKF and 2APB, however this blockage has no effect on the
downstream targets of AMPK and PGC1α. Further, loss of TRPC1 in EDL muscle
does not reduce the influx of Ca2+ due to AdipoRon treatment or PGC1α
expression, however it does reduce the phosphorylation of AMPK. Together this
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data indicates TRPC1 is most likely not a target channel for adiponectin signaling
and loss TRPC1 does not affect downstream effects.
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Results

Reduced expression of adiponectin targets in TRPC1-/- muscle
Our first step was to determine whether reduced serum adiponectin
concentrations in TRPC1-/- mice had an effect on the expression of genes targeted
by adiponectin in liver and muscle. These included PGC1α, lipid metabolism genes
of medium-chain acyl-CoA dehydrogenase (ACADM), fatty acid synthase (FASN),
and acetyl-CoA carboxylase (ACC) along with mitochondrial biogenesis genes
nuclear-encoded NRF1 (nuclear respiratory factor 1), mitochondrial transcription
factor A (TFAM), and estrogen-related receptor alpha (ERRα). Interestingly, the
two tissue types had differing expression levels even though they are both
adiponectin targets (Figure 42). Liver showed no change in PGC1α or
mitochondrial biogenesis genes, however TRPC1-/- mice had a significant increase
in the lipid metabolism genes FASN and ACC as compared to WT mice.
Conversely, muscle expression levels of TRPC1-/- mice were decreased in PGC1α,
lipid metabolism ACC and FASN mRNA, and mitochondrial biogenesis NRF1 and
ERRα. The muscle mRNA profile is similar to those reported due to decreases in
serum adiponectin concentrations (Civitarese et al., 2006), however more
investigation is needed to confirm.
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Figure 41 mRNA expression of lipid metabolism and mitochondrial
biogenesis genes in liver and muscle

Isolated mRNA from liver and bicep femoris muscle of WT and TRPC1-/- mice
were measured for the expression of peroxisome proliferator-activated receptor
γ coactivator 1α (PGC1α), lipid metabolism genes of medium-chain acyl-CoA
dehydrogenase (ACADM), fatty acid synthase (FASN), and acetyl-CoA
carboxylase (ACC) along with mitochondrial biogenesis genes nuclear-encoded
NRF1 (nuclear respiratory factor 1), mitochondrial transcription factor A (TFAM),
and estrogen-related receptor alpha (ERRα), n= 3. Graphs are mean ± SEM,
significance: *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
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Differentiated muscle cell line exhibits SOCE characteristics
Since muscle mRNA was reduced in TRPC1-/- mice, we investigated
whether this was a result of reduced adiponectin signaling in muscle due to a lack
of TRPC1 mediated Ca2+ influx. Before analyzing TRPC1 directly we first utilized
the C2C12 muscle cell line and differentiated the cells into mature myotubes and
measured Ca2+ influx and protein expression of SOCE proteins. Calcium imaging
results indicated a reduction in [Ca2+]i peak upon treatment of Tg (release of ER
stores) when cells were treated with either (10 uM) SKF or (100 uM) 2Aminoethoxydiphenyl borate (2-APB, an inhibitor of IP3 receptors and TRP

Figure 42 C2C12 myotubes exhibit SOCE properties
Quantification of Fura-2 trace peaks of [Ca2+]i after addition of 1 μM Tg and 1 mM
Ca2+ to differentiated C2C12 myotubes treated with either 10 uM SKF or 100 uM
2APB. Protein expression of SOCE proteins Stim1, TRPC1, and ORAI1 and
adiponectin receptors AdipoR1 and AdipoR2 in C2C12 myoblasts and myotubes.
Graphs are mean ± SEM, significance: **, p < 0.01; ***, p < 0.001.
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channels) (Figure 43). Upon the addition of 1 mM extracellular Ca2+, a reduction in
Ca2+ influx was observed in both SKF and 2APB treatments. This data confirms
earlier reports that SOCE is displayed within C2C12 myotubes (Stiber et al., 2008),
however, the administration of SKF and 2APB adversely affect ER store release.
To confirm the presence of SOCE in C2C12 myotubes, protein expression of
SOCE channels including STIM1, TRPC1, and ORAI1 was measured. Expression
of all three SOCE proteins was highly evident in differentiated C2C12 myotubes,
however expression of STIM1 and TRPC1 was minimal in undifferentiated C2C12
myoblasts (Figure 43). Together this data indicates mature C2C12 myotubes
exhibit SOCE characteristics and the STIM1, ORAI1, and TRPC1 complex may be
involved.

Blockage of SOCE reduces AdipoRon Ca2+ influx,
but not downstream targets
To test whether SOCE was involved in adiponectin signaling pathway in
muscle, we first confirmed the expression of the adiponectin receptors AdipoR1
and AdipoR2 in C2C12 cells. As shown, neither receptor is expressed in C2C12
myoblasts and only the AdipoR1 receptor is expressed in mature C2C12 myotubes
(Figure 43). Utilizing the synthetic adiponectin receptor agonist AdipoRon, we
measured the Ca2+ influx when SOCE channels are blocked. Administration of (50
uM) AdipoRon resulted in an immediate influx of Ca2+ in C2C12 myotubes which
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Figure 43 Blockage of SOCE reduces AdipoRon Ca2+ influx, but not
downstream targets in C2C12 myotubes
(A) Quantification of Fura-2 trace peaks of [Ca2+]i after addition of 50 uM
AdipoRon to differentiated C2C12 myotubes treated with either 10 uM SKF or
100 uM 2APB in a Ca2+ buffer. (B) Western blot quantification of ratio of pAMPK to AMPK after 5 min treatment with 50 uM AdipoRon with representative
blot in (D) n=7-13. (C) Relative mRNA expression of PGC1α after 90 min
treatment with 50 uM AdipoRon quantified by RT-PCR, n=6. Graphs are mean
± SEM, significance: *, p < 0.05, **, p < 0.01; ***, p < 0.001
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was completely diminished with treatment of (10 uM) SKF or (100 uM) 2APB
(Figure 44 A). We next tested whether this reduction in Ca2+ influx due to SKF and
2APB would alter the downstream signaling targets of AdipoR1 of AMPK and
PGC1α. C2C12 cells were pretreated with (10 uM) SKF and (100 uM) 2APB for 10
min and then treated with (50 uM) AdipoRon for an additional 5 min and activating
phosphorylation of AMPK was measured (Figure 44 B, D). As shown, AdipoRon
induced a significant increase in AMPK phosphorylation, however treatment with
SKF or 2APB had no effect. AdipoRon is known to induce increased expression of
PGC1α mRNA after 90 min (Okada-Iwabu et al., 2013), thus we quantified PGC1α
mRNA expression after pretreatment with (10 uM) SKF and (100 uM) 2APB for 10
min. Results are inconclusive as treatment with SKF and 2APB on PGC1α mRNA
is neither significantly increased from control or decreased from AdipoRon
treatment (Figure 44). Overall, these data suggest that adiponectin receptor
activation results in SOCE like Ca2+ influx, however blockage of SOCE is not
detrimental to the progression of the signaling cascade.

SOCE not diminished in primary muscle due to loss of TRPC1
Even though the downstream targets of AdipoR1 were not affected by
blockage of SOCE in C2C12 myotubes, we were still interested in whether TRPC1
may be involved in adiponectin signaling in either a SOCE or SOCE independent
manner. First, WT EDL muscle fibers were isolated and individually cultured to
activate muscle satellite cells. Upon confluence, EDL myoblasts will naturally
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B

Figure 44 WT EDL muscle exhibits SOCE mediated Ca2+ influx which is
not diminished by loss of TRPC1
EDL muscle was isolated from WT and TRPC1-/-, cultured, and differentiated
into mature EDL myotubes as described in Methods. (A) Quantification of Fura2 trace peaks of [Ca2+]i after addition of 1 μM Tg and 1 mM Ca2+ to WT EDL
myotubes treated with either 10 uM SKF or 100 uM 2APB. (B) Quantification
of Fura-2 trace peaks of [Ca2+]i after addition of 1 μM Tg and 1 mM Ca2+ to WT
and TRPC1-/- EDL myotubes treated with either 10 uM SKF or 100 uM 2APB.
Graphs are mean ± SEM, significance: **, p < 0.01.

differentiate into myotubes with twitching observed around day 7. We first
established whether primary WT EDL muscle cultures exhibit the same SOCE
mechanisms as C2C12 cells by blocking SOCE channels with SKF or 2APB. As
seen in Figure 45 A, WT EDL efflux relatively the same from ER stores upon
treatment with Tg, however treatment with either (10 uM) SKF or (100 uM) 2APB
reduced the influx of Ca2+ upon addition of 1 mM Ca2+. We next tested TRPC1-/128

EDL in the same manner. As compared to WT EDL, TRPC1-/- displayed no
significant change in either ER store efflux due to Tg or Ca2+ influx due to addition
of 1 mM Ca2+ to the extracellular solution (Figure 45 B). Together this indicates
that EDL muscle do exhibit SOCE mechanisms, however loss of TRPC1 does not
affect it.

Initial influx of Ca2+ due to treatment with AdipoRon
is not TRPC1 dependent
To determine the involvement of TRPC1 in adiponectin signaling, we first
confirmed the expression of AdipoR1 in both WT and TRPC1-/- EDL. Neither WT
or TRPC1-/- EDL express AdipoR2 and no difference of AdipoR1 expression was
observed between WT and TRPC1-/- EDL (Figure 46, B). The next step was to
measure the response of WT EDL to AdipoRon when SOCE mechanisms are
blocked. AdipoRon administration resulted in a significant increase in Ca2+ influx
which was blocked when treated with (10 uM) SKF or (100 uM) 2APB (Figure 46
A). Comparison of Ca2+ influx upon treatment of AdipoRon resulted in no significant
difference between WT and TRPC1-/- EDL (Figure 46 C). So far, this data indicates
that treatment with the adiponectin receptor AdipoRon does not initiate a Ca2+
influx via TRPC1.
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Figure 45 AdipoRon initiated Ca2+ influx is not TRPC1 dependent
(A) Quantification of Fura-2 trace peaks of [Ca2+]i after addition of 50 uM
AdipoRon to differentiated WT EDL myotubes treated with either 10 uM SKF or
100 uM 2APB in a Ca2+ buffer. (B) Protein expression of AdipoR1 and AdipoR2
in WT and TRPC1-/- EDL. (B) Quantification of Fura-2 trace peaks of [Ca2+]i
after addition of 50 uM AdipoRon to differentiated WT and TRPC1-/- EDL
myotubes in a Ca2+ buffer. Graphs are mean ± SEM, significance: ***, p <
0.001.

Loss of TRPC1 in EDL impairs the ability of AdipoRon to initiate
downstream targets of adiponectin signaling
The final step to determine involvement of TRPC1 in adiponectin signaling
was to monitor the effects of AdipoRon on downstream targets of AMPK and
PGC1α in TRPC1-/- EDL. Addition of AdipoRon to WT EDL resulted in a more than
2 fold increase in phosphorylation of AMPK after 5 minutes (Figure 47 A, B). When
the same treatment was applied to TRPC1-/- EDL, there was a slight increase in
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phosphorylation of AMPK, however it was not enough to be significant. Moreover,
comparison of TRPC1-/- to WT indicated loss of TRPC1 significantly reduced
phosphorylation of AMPK initiated by AdipoRon treatment (Figure 47 A, B).
Expression changes of PGC1α mRNA were next examined and found that loss of
TRPC1 in EDL myotubes reduced the ability of AdipoRon signaling. Significant
increases in PGC1α mRNA observed in WT EDL upon AdipoRon treatment were
not observed in TRPC1-/- EDL (Figure 47 C). The combined results of activation of
p-AMPK and PGC1α indicates that TRPC1 may be indirectly involved with in the
function of adiponectin signaling.
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Figure 46 Loss of TRPC1 in EDL impairs the ability of AdipoRon to
activate AMPK
(B) Western blot quantification of ratio of p-AMPK to AMPK in WT and TRPC1/-

EDL after 5 min treatment with 50 uM AdipoRon n=6, representative blot in

(A). (C) Relative mRNA expression of PGC1α in WT and TRPC1-/- after 90 min
treatment with 50 uM AdipoRon quantified by RT-PCR n=6. Graphs are mean
± SEM, significance: *, p < 0.05, **, p < 0.01; ****, p < 0.0001.
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Conclusion
Within this study our aim was to extend the understanding of Ca2+
involvement, specifically SOCE, in adiponectin signaling to determine whether
decreases in PGC1α expression and other targets in TRPC1-/- muscle are a result
of decreased signaling capabilities. We employed the use of both the immortalized
cell line C2C12 and primary EDL skeletal muscle to determine the role of SOCE
activation due to AdipoR1 activation. Here we are the first to show that AdipoRon
initiates Ca2+ influx that can be blocked by SKF and 2APB, however these
treatments do not affect downstream targets. Finally, we were able to determine
that loss of TRPC1 does not inhibit the influx of Ca2+ due to AdipoRon, but does
diminish AMPK phosphorylation. Collectively, these results identify SOCE
involvement in adiponectin, but TRPC1 may not be playing a role.
Increased hepatic lipogenesis is a common feature of obesity. Elevated
expression of both FASN and ACC have been correlated to obesity (Beaven et al.,
2013; Dentin et al., 2006), with the enzyme FASN considered a determinant of
maximal tissue capacity of lipid storage (Postic and Girard, 2008) and blockage of
ACC has been shown to reduce excess liver lipid accumulation in mice on a highfat diet (Savage et al., 2006). Within our model, the increased expression of FASN
and ACC observed in TRPC1-/- liver indicates an increase in lipogenesis and could
be indicative of an obese phenotype. Multiple theories have surfaced as to why
increased liver lipogenesis is observed in an obese state. These include the
absence of functional adipocytes resulting in an increase of fatty acids being
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pushed to the liver (Yki-Järvinen, 2005) and low serum adiponectin concentrations
negatively affecting liver functionality (Viganò et al., 2011). Further investigation is
needed to determine the cause of reduced FASN and ACC in TRPC1-/- which could
be due to dysfunctional adipocytes or liver.
Muscle is similarly affected by the onset of obesity. Accumulation of lipid in
skeletal muscle due to high levels of adipose tissue lipolysis or impaired blood lipid
clearance by adipose tissue is known to result in insulin resistance and
hyperglycemia in skeletal muscle (Stern et al., 2016). Adiponectin is known to
offset the negative effects of obesity by encouraging fatty acid oxidation in skeletal
muscle thereby decreasing intramuscular lipid accumulation and improving insulin
sensitivity (Civitarese et al., 2006; Fruebis et al., 2001; Yamauchi et al., 2002).
Similar to adiponectin KO mice (Civitarese et al., 2006), we observed a decrease
in PGC1α, lipid metabolism, and mitochondrial biogenesis genes in TRPC1-/muscle. This lead us to investigate whether this phenomenon is due to decreased
circulating adiponectin concentration(s) or decreased adiponectin signaling.
The small molecule agonist AdipoRon was developed by Okada-Iwabu et
al. in 2013 which is orally active and binds and activates both AdipoR1 and
AdipoR2. AdipoRon is known to increase AMPK phosphorylation, PGC1α, and
mitochondrial content making it a useful tool in studying adiponectin signaling.
Interestingly, knockdown of AdipoR1/2 or blockage of Ca2+ by EGTA diminishes
the benefits of AdipoRon in muscle (Okada-Iwabu et al., 2013). Within our study,
the combination of SKF or 2APB with AdipoRon in C2C12 cells completely
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abolished the immediate influx of Ca2+ seen in the AdipoRon only cells. However,
blockage of SOCE currents had no effect on p-AMPK or PGC1α most likely
indicating a Ca2+ independent mechanism within adiponectin signaling. As seen in
Figure 41, liver kinase B1 (LKB1) is also known to phosphorylate AMPK and in our
model, could be compensating for the lack of Ca2+ normally seen. More
investigation is needed to determine whether LKB1 is compensating for blocked
Ca2+, however we can determine from our data that SOCE is a partial but not a
mandatory component of AdipoR1 signaling.
Examination of WT EDL produced similar results to the C2C12 myotubes
where SOCE was initiated by treatment with AdipoRon and blocked by SKF and
2APB. When comparing AdipoRon induced Ca2+ influx in TRPC1-/- to WT EDL, we
saw no change due to the loss of TRPC1. Importantly, expression in AdipoR1 in
WT and TRPC1-/- EDL muscle was similar indicating increased or decreased
binding of AdipoRon to AdipoR1 due to receptor expression changes had no effect
on the amplitude of Ca2+ influx. This is relevant as muscle and hepatic protein
levels of AdipoR1 are significantly reduced in obesity (Lustig et al., 2014), further
indicating that reduced expression of downstream targets of adiponectin signaling
in TRPC1-/- muscle is due to substrate loss. Interestingly, though there is no
change in AdipoRon mediated Ca2+ influx due to TRPC1 loss, we did observe
reduced AMPK phosphorylation. This reduction in AMPK phosphorylation may still
be linked to loss of TRPC1, however through a different mechanism. Calcium entry
via TRPCs has been found to be necessary for thrombin-induced nuclear factor
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kappa-light-chain-enhancer of activated B cells (NF-κB) through AMPK
phosphorylation in endothelial cells (Bair et al., 2009) which may be relevant to
muscle function. Whether TRPC1 is linked to the reduced phosphorylation of
AMPK in our EDL muscle, does not explain how loss of TRPC1 failed to reduce or
increase PGC1α expression significantly. The evidence of this study suggests that
TRPC1 does not have a role in AdipoRon mediated SOCE and TRPC1 loss in
muscle is most likely not the cause of reduced PGC1α, lipid metabolism and
mitochondrial biogenesis mRNA expression.
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CHAPTER VII
DISCUSSION

The role of Ca2+ homeostasis in adipose tissue biology has garnered
increased attention in recent years due to its connection with metabolic disorders
(Arruda and Hotamisligil, 2015). The purpose of this dissertation is to expand this
knowledge base with hopes that the information can someday be used for
therapeutic interventions. The evidence provided highlights a central role for
TRPC1 in regulating the Ca2+ dependent processes of differentiation, autophagy,
and adipokine secretion in adipose tissue.
TRPC1 and SOCE mechanisms in adipose tissue have recently been
identified in the 3T3-L1 cell line (El Hachmane et al., 2018; Sukumar et al.,
2012), however no work has been done to confirm this in vivo. The work provided
here is the first to identify TRPC1 dependent SOCE in primary cell cultures from
isolated mouse Subc AT and VAT SVF. In both tissue types, it was identified that
SOCE was present in SVF with TRPC1-like currents and that upon
differentiation, these currents were amplified with concurrent increases in STIM1
and TRPC1 protein expression. Genetic ablation of TRPC1 reduced SOCE in
both Subc AT and VAT SVF and differentiated adipocytes further confirming its
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role in SOCE. In differentiated VAT, an ORAI1-like current was observed,
however there was no change in ORAI1 protein expression and ORAI1 was not
able to compensate for the loss of TRPC1, suggesting that the major Ca2+ entry
channel in adipocytes is mediated via TRPC1.
By focusing on adipose tissue function, we’ve identified multiple metabolic
regulatory functions to be dependent on TRPC1-mediated Ca2+ influx. Herein, it
was shown that loss of TRPC1 impaired adipocyte differentiation which seems to
be a result of inhibited PPARy expression. Further, TRPC1-/- animals fed a highfat diet and exercised exhibited a reduction in autophagy with a concurrent
increase in apoptosis. Together these phenomena may be linked as it has been
shown that a reduction in autophagy impairs adipogenesis (Baerga et al., 2009;
Singh et al., 2009), however these studies suggest that later transcriptional
events such as the upregulation of FABP4 and perilipin to be more severely
impacted by decreased autophagy rather than PPARy in early adipogenesis.
Overall the data suggests that TRPC1-/- mice have impaired adipogenesis which
in the long-term may result in hypertrophic obesity, however if the animals are
stressed through diet and exercise, adipogenesis is further impaired by TRPC1mediated reduction in autophagy resulting in apoptosis and fat mass loss.
The other portion of this dissertation which contributes to the metabolic
dysfunction due to TRPC1 loss in adipose tissue is the investigation of
adiponectin secretion. Ex-vivo experimentation of insulin-stimulated adiponectin
secretion from TRPC1-/- adipose tissue revealed that decreased secretion is
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likely due to the lack of TRPC1-mediated Ca2+ influx necessary for SNARE
complex formation and not reduced internal adipose tissue adiponectin stores.
Further, analysis of serum adiponectin revealed TRPC1-/- mice to have reduced
concentrations when fed either a high-fat or normal-fat diet as compared to WT.
Additionally, these same mice had no change in fat mass, blood glucose, insulin,
or insulin resistance as calculated by HOMA IR. This is contrary to a multitude of
studies that show a correlation between reduced serum adiponectin
concentrations and increased fat mass, blood glucose, insulin, and insulin
resistance typically observed in obesity (Abdelgadir et al., 2013; Berg et al.,
2001; Kou et al., 2018). Together, this data further indicates a non-obesity
induced reduction in serum adiponectin. Exercise was able to recover serum
adiponectin concentrations in TRPC1-/- fed either a high-fat or normal-chow diet.
This may be due to the ability of exercise to increase adiponectin secretion from
muscle through PPARy activation (Amin et al., 2010) and increased AdipoR1
expression (Tsuchida et al., 2004; Zeng et al., 2007) thereby bypassing
dysfunctional adiponectin secretion from adipose tissue.
Current modeling of adiponectin signaling indicates a direct linkage
between AdipoR1 activation, Ca2+ influx, and AMPK phosphorylation however
data from C2C12 cells with blocked SOCE and TRPC1-/- EDL suggests a
different mechanism. In TRPC1-/- EDL, AdipoRon initiated Ca2+ influx was
unchanged, however a reduction in AMPK phosphorylation was observed along
with an inconclusive PGC1α mRNA change. This may indicate an indirect
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reduction in stimulation or increased inhibition of AMPK due to TRPC1 loss that
needs to be further researched. This, however, is likely not the cause of the
significant reduction in PGC1α, FASN, and ACC observed in TRPC1-/- muscle
and instead is the result of reduced serum adiponectin concentrations.
In closing, this dissertation efficiently describes the role of TRPC1 in
modulating critical Ca2+ mediated processes within adipose tissue which in turn
effects whole body metabolic homeostasis.
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